Volume 14; Issue supp-S3

Main
European Neuropsychopharmacology
Volume 14; Issue supp-S3

European Neuropsychopharmacology

Volume 14; Issue supp-S3

1

L.2 Children and adolescents: The future of psychiatry

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 126 KB

english, 2004

2

S.01.01 Early warning signs in bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

3

S.01.04 What is the role psychological therapies inthe treatment of bipolar disorders?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

4

S.01.05 Are novel antipsychotics as effective as anticonvulsants or lithium on the long-term treatment of bipolar disorder?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

5

S.02.02 Neuropathology of dementias

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

6

S.02.04 Lewy body disease: How are dementiawith Lewy bodies and Parkinson's disease dementia related?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 244 KB

english, 2004

7

S.02.05 Glutamate antagonist for dementia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

8

S.03.02 Polymorphysm of 5-HT1d in obsessivecompulsive disorder

L. Bellodi, D. Di Bella, S. Erzegovesi, M.C. Cavallini

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

9

S.03.03 5HT1D as a dimension for repetitive behaviour

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

10

S.03.04 5HT1D hypothesis of OCD — an update

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

11

S.03.05 5-HT1B/1D a potential target for anti depressants/anxiolytics

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 240 KB

english, 2004

12

S.04.01 Diverse psychotomimetics act through a common signaling pathway

P. Svenningsson, E.T. Tzavara, R. Carruthers, G.G. Nomikos, P. Greengard

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

13

S.04.02 Neurobiological and behavioral effects of chronic mild stress in glucocorticoid receptor-impaired transgenic mice

N. Froger, E. Palazzo, C. Boni, N. Hanoun, C. Joubert, I. Dutriez-Casteloot, N. Barden, C. Cohen-Salmon, M. Hamon, L. Lanfumey

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

14

S.04.03 Leptin treatment in activity-based anorexia

J. Hillebrand, M. Kas, A. Scheurink, G. van Dijk, A. Adan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

15

S.04.04 Temporal and anatomical characterization ofstress-related changes on BDNF expression in the rat central nervous system

R. Molteni, F. Fumagalli, M. Roceri, F. Bedogni, F. Cirulli, G. Racagni, M.A. Rival.

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

16

S.04.05 Changes in subunit composition of N-methyl-D-aspartate receptor in animal model of schizophrenia: Effect of subunit selective antagonist

I. Skuba, H. Tejkalová, F. Št'astný

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

17

S.04.06 Prefrontal cortex dysfunction in ananimal model for neurodevelopmental psychopathological disorders

L. Diergaardei, L. Groeninki, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

18

S.04.07 Neuroimaging changes in an animal model of schizophrenia

C. Risterucci, K. Jeanneau, J.L. Moreau, S. Schoeppenthau, T. Bielser, B. Kuennecke, M. Von Kienlin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

19

S.04.08 Hypothalamic histochemistry in different genetic models of anorexia

S.O. Fetissov, J.E. Johansen, C. Broberger, L.C. Byrne, Z. Zhou, K. Tryggvason, M. Schalling, B. Ranscht, T. Hökfelt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

20

S.06.04 Visual processing of (un)masked facial affectin euthymic bipolar patients

R.S. Kahn, A.C. van der Schot, N.F. Ramsey, M. Vink, J. Majdandzic, W.A. Nolen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

21

S.06.05 Relevance of neuroplasticity and cellularresilience in bipolar disorder and depression: Evidence from neuroimaging and cognitive studies

P. Fossati, P. Boyer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

22

S.07.01 Anxiogenic drugs act selectively ontopographically distinct midbrain, pontine,and medullary serotonergic neurones

J.K. Abrams, P.L. Johnson, A. Shekhar, C.A. Lowry

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

23

S.07.02 Identification of GABAA receptor subtypesinvolved in tolerance against the sedative action of diazepam

C. van Rijnsoever, M. T↑ber, U. Rudolph, J.M. Fritschy, F. Crestani

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

24

S.07.03 GABAB receptors play a key rolein the modulation of anxiety and antidepressant-related behaviour: Genetic and pharmacological evidence

C. Mombereau, K. Kaupmann, W. Froestl, H. van der Putten, J.F. Cryan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

25

S.07.04 Association between serotonin-relatedgenetic polymorphisms and cholecystokinin tetrapeptide induced panic attacks in healthy volunteers

E. Maron, G. Tasa, J. Tõru, A. Lang, V. Vasar, I. Shlik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

26

S.07.05 Rivastigmine therapy for memory deficits in schizophrenia patients receiving electroconvulsive treatment

D. Ophir, R. Stryer, F. Bar, A. Ullman, R.D. Strous, M. Kotler, A. Weizman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

27

S.07.06 Brain volume changes in patients withschizophrenia: A 5-year longitudinal MRI study across the course of illness

N.E.M. van Haren, H.E. Hulshoff Pol, W. Cahn, H.G. Schnack, R. Brans, A.J. Laponder, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

28

S.07.07 Stimulation of a1-adrenergic and AMPAreceptors in rat medial prefrontal cortex increases local in vivo serotonin release: Reversal by antipsychotic drugs

M. Amargós-Bosch, A. Adell, F. Artigas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

29

S.07.08 Brain networks in sleep as revealed by combined EEG and fMRI

R. Wehrle, M. Czisch, C. Kaufmann, T.C. Wetter, F. Holsboer, D.P. Auer, T. Pollmächer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

30

S.08.03 Heterogeneity of glutamatergic neurons inthe central nervous systems revealed by the distribution of vesicular glutamate transporter subtypes

S. El Mestikawy, A. Kashani, C. Gras, J. Gilchrist, M. Bournaud, B. Giros

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 240 KB

english, 2004

31

S.08.04 Amino acid transporters as therapeutic targets in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 240 KB

english, 2004

32

S.08.05 Group I mGIuR receptors in rodent models for schizophrenia

M.A. Geyer, S.A. Brody, F. Conquet

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 124 KB

english, 2004

33

Comparing side-effects across the atypical antipsychotics

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

34

S.09.03 How to choose the right dose ofantipsychotics — lessons from neuroimaging studies

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 241 KB

english, 2004

35

S.11.02 Cannabinoid CB1 receptors and memory function

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 245 KB

english, 2004

36

S.11.03 Cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism as potential therapeutic drugs

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

37

S.11.04 Endocannabinoids — intrepid defenders of the nervous system

R. Mechoulam, D. Panikashvili, E. Shohami

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

38

S.12.02 Vaccination against beta-amyloid inAlzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

39

S.13.02 Omega-3 fatty acid treatment in depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

40

S.13.05 Peptide approaches in the treatment of major depression — lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant

S.A. Montgomery, M. Keller, W. Ball, M. Morrison, D. Snavely, G. Liu, C. Lines, K. Beebe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

41

S.14.01 Is pediatric mania a developmental subtype ofbioolar disorder?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 126 KB

english, 2004

42

S.14.03 Biological studies in childhood affectivedisorders

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

43

S.15.01 Mode of action of atypical antipsychotic drugs:Focus on α2 adrenoceptors

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 126 KB

english, 2004

44

S.15.02 Amino-acid transport in schizophrenia

F.A. Wiesel, L. Bjerkenstedt, L. Flyckt, G. Edman, N. Venizelos

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

45

S.15.03 Neuregulin 1 and schizophrenia

H. Stefansson, V. Steinthorsdottir, J. Guloher, K. Stefansson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

46

S.15.04 The α7 nicotinic receptor as a potential peripheral marker for schizophrenia

S. Fuchs, O. Perl, T. Ilani, R.D. Shone

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

47

S.15.05 PPI, habituation and sensitization of startlereflexes in schizophrenia

U. Meincke, K. Heekeren, E. Gouzoulis-Mayfrank

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 122 KB

english, 2004

48

S.16.01 Designing stem cells as therapeutic agents inneurological disease

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

49

S.16.03 Neural stem cell and brain repair

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

50

S.17.03 Atypical antipsychotics in social anxiety (SAD)and posttraumatic stress disorder (PTSD)

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

51

S.17.05 Role of atypical antipsychofics in the anxiety-depression spectrum

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

52

S.18.01 Mortality in mood-disorder patients with and without long-term medication

J. Angst, F. Angst, R. Gerber-Werder, A. Gamma

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

53

S.18:01 Do SSRIS induce suicide? A controlled studyof Swedish suicides 1992–2000

G. Isacsson, P. Holmgren, I. Ahlner

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

54

S.18.03 An evidence-based approach to reducing the risk of suicide in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

55

S.18.04 Monoamine measures in suicide brains

B. Arranz, Benito Menni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

56

S.18.05 SPECT-studies of suicide attempters

C. van Heeringen, K. Audenaert, K. Bernagie, M. Vervaet, F. Jacobs, R. Dierckx

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

57

S.19.01 Alzheimer's disease: The search for surrogatebiomarkers

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

58

S.19.02 Cognitive genomics and schizophrenia:Implications for drug targets

T.E. Goldberg, M.F. Egan, R.F. Straub, D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

59

S.19.03 An inducible gene knockout system targeted to BDNF in the brain

L.M. Monteggia, M. Barrot, C.M. Powell, O. Berton, V. Galanis, S. Meuth, A. Nagy, R.W. Greene, E.J. Nestler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

60

S.19.05 Development of molecular targets for understanding and treating stress-related disorders

M.J. Owens, N. Hanson, D.A. Gutman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 241 KB

english, 2004

61

S.20.01 Candidate genes for substance dependence:Evidence from expression profiling studies

W. Sommer, C. Arlinde, R. Rimondini, A.C. Hansson, P. Hyytiä, F.R. deFonseca, M. Heilig

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 248 KB

english, 2004

62

S.20.02 Clock genes and addiction

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 243 KB

english, 2004

63

S.20.03 Effects of NOS inhibitors on ethanol intoxication and withdrawal

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 242 KB

english, 2004

64

S.20.04 Glutamatergic mechanisms underlyingnicotine addiction

A. Markou, P.I. Kenny, N.E. Paterson, S. Semenova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

65

S.21.02 Vulnerability, risk factors, course and outcomeof specific anxiety disorders: Evidence for dimensional perspectives?

H.U. Wittchen, A. Bittner, R. Lieb

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

66

S.21.03 Can CO2 be used to model different anxiety disorders?

D.J. Nutt, J.E. Bailey

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 237 KB

english, 2004

67

S.21.04 Early diagnosis and treatment response inanxiety disorders

E. Mund, A. Santini, D. Salvadori, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

68

S.22.01 Linking the biology, phenomenology and pharmacology of psychosis — a feasible project or just a delusion

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

69

S.22.02 Neural networks and antipsychotics: What can we learn from functional MRI and MR-spectroscopy?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

70

S.23.01 Caffeine as an adenosine receptor antagonist

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 238 KB

english, 2004

71

S.23.02 Interaction between caffeine and the dopaminergic system

N. Simola, O. Cauli, A. Pinna, C.T. Chopde, M. Morelli

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 240 KB

english, 2004

72

S.23.03 The basis of stimulant effects of caffeine and possible role of adenosine A2A receptors in depression

I.M. Vaugeois, M. El Yacoubi, I. Costentin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 243 KB

english, 2004

73

S.23.04 Adenosine receptor polymorphisms and the actions of caffeine

I. Deckert, K. Alsene, P. Sand, H. deWit

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 240 KB

english, 2004

74

S.23.05 Caffeine and sleep

T. Porkka-Heiskanen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

75

S.24.01 Evolutionary aspects of peptides

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 244 KB

english, 2004

76

S.24.03 Neuropeptides and epilepsy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

77

S.25.02 Agonist assisted vs drug free intensivepsychosocial treatment in heroin dependence

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

78

S.25.04 Matching treatment to patients in heroin assisted treatment of methadone resistant heroin dependent patients: Results of two randomised controlled trials

W. van den Brink

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

79

S.25.05 Medication development for cocaine dependence

W. Ling, S. Shoptaw, R. Rawsonl, F. Voccn

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

80

S.26.01 Brain sensitivity to negative emotionalchallenge in anxiety disorder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

81

S.26.02 Imaging facial emition processing

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 242 KB

english, 2004

82

S.26.03 Imaging the pharmacotherapy of anxiety disorders

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 122 KB

english, 2004

83

S.27.03 Neuroprotection therapies for Huntington's disease

E. Prouilld, C. Jacquardrd, P. Hantreyt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 125 KB

english, 2004

84

S.27.04 Genetic aetiopathogenesis of Parkinson's disease

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

85

S.27.05 Genes and oxidative stress

E. Grünblattl, S. Mander, J. Li, N. Amarirlio, I. Yaakov, G. Rechavi, W. Rorrendor, S. Hoyerb, M.B.H. Youdim, R. Riederer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

86

S.28.01 Serotonin and neurodevelopment: The rodent somatosensory system paradigm

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

87

S.28.02 Implication of adenylate cyclase in synaptic remodelling of svnaotic circuits

R. Gaspar, X. Nicol, A. MuzereAle, A. Ravary

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

88

S.28.03 Molecular genetics of serotonin neuron development and function

E.S. Deneris, M.M. Scott, J.T. Erichon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 245 KB

english, 2004

89

S.28.04 Neuronal morphology in serotonergic gene knock-out mice

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 185 KB

english, 2004

90

P.1.001 Basal prolactin values correlate with response to reboxetine treatment in depressed patients, but not with response to citalopram

O. Moefer, G. Hetael, M. Rothermundt, V. Arolt, A. Erfurth

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

91

P.1.002 Definitions of mixed depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 208 KB

english, 2004

92

P.1.003 The structure of hypomania

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

93

P1.004 Quetiapine in the treatment of agitation in major depressive disorder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

94

P.1.005 Venlafaxine extended release versusconventional antidepressants in depressive patients

C. Leal, E. Haca, J. Ginert, I. Vallejo, R. Prieto, C. Garcia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

95

P.1.006 Efficacy and safety in outpatient double-blind,placebo-controlled study comparing 30 mg and 45 mg of nemifitide versus placebo in subjects diagnosed with melon depression

S.T. Montgomery, J.P. Feiahner, L. Sverdlov, J. Hlavka, G. Tonelli, J. Freed

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

96

P.1.007 Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers

Y.K. Kim, A.M. Myint, C.S. Han, H.W.M. Steinbusch, M. Maes, B.E. Leonard

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

97

P.1.008 Substance abuse in schizophrenia: Data froma cost-effectivenes trial

S.L. Tunis, A.W. Nyhuis, D.E. Faries, B.J. Kinon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

98

P.1.009 Misdiagnosis of bipolar disorder as unipolar depression: A problematic differential diagnosis in clinical practice

M.D. Stensland, N. deLay, M. Ciaglia, S. Visawanathan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

99

P.1.010 Vigilance and driving skills in healthyvolunteers — effect of the dual-action antidepressant, milnacipran

E. Pancani, F. Richet, J. Marais, C. Serre

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 222 KB

english, 2004

100

P.1.011 Absence of interaction of milnacipran with the cytochrome P450 system — evidence from human volunteer studies

C. Puozzo, S. Lens, C. Reh, K. Michaelis, D. Rosillon, X. Deroubaix, P. Hermann, D. Deprez

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

101

P.1.012 Double-blind comparison of adverse eventsfollowing withdrawal after treatment with milnacipran and paroxetine in depressed patients

P. Vandel, D. Sechter, E. Weiller, N. Puzous, F. Cabanac, A. Tournoux

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

102

P.1.013 Antidepressant induced sexual dysfunction in Europe: A preliminary investigation

V.S.L. Willams, S.E. Fehnel, K.A. Hollis, S.L. Hogue

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

103

P.1.014 Comparison of mania ratings across three cultures

S.D. Targum, A. Young, A.H. Kalali

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

104

P.1.015 Modafinil for major depression with atypical features

K. Connor, K. Gadde, W. Zhang, V. Payne, J. Davidson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 210 KB

english, 2004

105

P.1.016 Validation of a simplified definition of anger attacks

D. Winker, E. Pjrek, N. Praschak-Rieder, M. Willen, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

106

P1.017 Clinical picture of anger attacks in fall-winter depression

E. Pjrek, D. Winkler, A. Konstantinidis, N. Praschak-Rieder, M. Willen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

107

P1.018 Acute effect of locuson the relationshipbetween the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters

T. Bandoh, M. Hayashi, K. Hoshi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

108

P.1.019 ucb 46331, a new putative antidepressant agent: Pharmacological properties in vitro and in vivo

C. Genicotl, B. Fukcs, B. Christophe, R. Grimée, O. Bertont, D. Dassesse, A. Matagnet, M. Guyaux, T. Waegemans, Y. Lamberty

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 123 KB

english, 2004

109

P.1.020 ucb 46331, a new putative antidepressant agent: Efficacy in animal models of depression and anxiety

C. Drieu La Rochelle, M. Lemaire, C. Genicot

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

110

P.1.021 Complete remission of severe individualsymptoms of depression: A comparison of venlafaxine, SSRIs, and placebo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

111

P1.022 Antidepressive therapy as possibility toimprove clinical current and compliance to treatment of arterial hypertensive patients with depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

112

P.1.023 Frontal cerebral perfusion after nortriptyline treatment versus citalopram treatment in elderly major depression: A 12-month follow-up control study

V. Navarro, F. Lomena, C. Gató, J.J. Mateos, T. Marcos

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

113

P1.024 Venlafaxine XR for depression: Real-world remission data in primary careR. Mora S. Ros M. Garcia-Garcia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

114

P.1.025 Depression and anxiety as related to time andsize of hormone responses to 5-HT-, NE- and DA-challenge tests in healthy subjects

P.S. Netter, M. Reuter, B. Schroeckert, C. Toll, J. Hennig

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 214 KB

english, 2004

115

P.1.026 Chronobiological thyrotropin and prolactin responses to TRH and prognosis of depression

F. Duval, J. Monreal, M. Valdebenito, J.P. Macher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

116

P.1.027 HPA and HPT axis dysfunction in depression:Dopaminergic and noradrenergic correlates

F. Duval, M.-C. Mokrani, J. Monreal, S. Fattah, J.-P. Macher, F. Duval

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

117

P.1.028 Persistent reduction in brain 5-HT1A receptorbinding in recovered depressed men using positron emission tomography and [11C]WAY-100835

Z. Bhagwagar, E.A. Rabiner, R.A. Sargente, P.M. Grasby, P.J. Cowen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

118

P.1.026 Efficacy of sertraline in an anxious subgroupof youths with major depression

K.D. Wagner, P. Ambrosini, J. Gillespie, R. Yang

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

119

P.1.030 Mirtazapine augmentation of citalopram accelerates response in OCD patients without comorbid depression: A pilot study

L. Quercioli, M. Bruscoli, S. Pallanti

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

120

P.1.031 Multihormonal correlates of personalitydimensions in depression

J.A. Monreal Ortiz, F. Duval, M.C. Mokrani, G. Pinault, L. Staner, M.L. Atsé, J.P. Macher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

121

P.1.032 Mirtazapine vs SSRls: A meta-analysis on onset of antidepressant activity in more than 2500 patients with major depression

C. Thompson, A.P.P. Willigenburg, A. Heukels, C. Janssens, A.J. Schutte

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

122

P.1.033 Combining two antidepressant drugs fromtreatment initiation: A preliminary analysis

P. Blier, C. Hebert, H. Ward

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

123

P.1 .034 Efficacy of mirtazapine vs. SSRls in anxietysymptoms associated with major depression: A pooled data analysis

M. Fava, A.J. Schutte, A.P.P. Willigenburg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

124

P.1.035 An open study of instant dose citalopram inpremenstrual dysphoric disorder

A.V. Ravindran, S. Woods, M. Steiner

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

125

P.1.036 Menopausal duration, cognitive function during hormone replacement therapy with SSRls in postmenopausal women with depression

S.H. Joe, Y.H. Ko, Y.J. Seo, I.K. Jung, H.W. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

126

P.1.037 A study for clinical guideline of hypothyroidism during lithium maintenance therapy

D.I. Yoon, G.H. Bahn

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

127

P.1.038 Depression in obsessive compulsive disorder: What is the symptomatic profile?

N. Fineberg, H. Fount, T.M. Gale, T. Sivakumaran

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

128

P.1.039 Long-term efficacy and safety of venlafaxine ER in children and adolescents with major depressive disorder

G.J. Emslie, P.P. Yeung, N.R. Kunz, Y. Li

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 215 KB

english, 2004

129

P.1.040 Efficacy of duloxetine treatment: Analysis of pooled data from six placebo- and SSRI-controlled clinical trials

R.W. Swindle, C.H. Mallinckrodt, J.F. Rosebaum, Y. Lu, J.G. Watkin, P. Ghandi, M.J. Detke

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

130

P.1.041 Mirtazapine IV in medically ill patients: Firstreport in Mexico

A. Morlet-Barjau, J. Cortes-Sotres

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

131

P.1.042 Efficacy and tolerability of depressioninthe treatment of major depression due to Parkinson disease

R. Weiser, J. Hernandez-Rojas, M. Gallardo, M.L. García, M. Grau, J. Flores

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

132

P.1.043Onset of antidepressant efficacy in depressed patients treated with mirtazapine fast dissolving tablet versus sertraline

R.A. Baker, A.J. Schutte

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

133

P.1.044 Does childhood and adult obsessive compulsive disorder (OCD) respond the same way o treatment with serotonin reuptake inhibitors (SRIs)

N. Fineberg, I. Heyman, R. Jenkins, P. Premkumar, D. Veale, T. Kendall, M. Freeston

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

134

P.1.045 Clinical assessment of vs. SSRIefficacy in major depressive episode

C. Tudor, M.D. Gheorghe, G. Grigorescu, D. Marinescu

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

135

P.1.046 A day-to-day experience withmirtazapine, a new NaSSA antidepressant, in the treatment of depressed patients in the practice

A. Delini-Stula, R. Bischof, A. Desax

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

136

P.1.047 Antidepressant efficacy and patent's acceptance of a new formulation of mirtazapine in depressed patients in the practice

A. Delini-Stula, R. Bischof, A. Desax

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

137

P.1.048 Some neurochemical effects of tramadol in therat brain resemble the effects of antidepressant drugs

A. Faron-Górecka, M. Kuśmider, S.Y. Inan, J. Siwanowicz, M. Dziedzicla-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

138

P.1.049 Psychostabilizers in management of bipolar affective disorders

J. Timotijevic, L. Stefanovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

139

P.1.050 Effects of valproate on leukocyte phagocytosis in mice and in a rat model of depression

J. Pistovcakova, A.E. Sulcova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

140

P.1.052 Multinational inter-rater consistency across six separate investigator meetings

S.D. Targum, I. Mullen, B. Paulsson, R. Vasovicova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

141

P.1.053 Absence of weight gain during long-termtreatment of major depressive disorder with gepirone ER

S.P. Roose, R. van Maanen, M. Gibertini, J.H. Simmons, N. Ivgy-May, R.A. Baker

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

142

P.1.054 Interactions of vascular risk/disease andapolipoprotein E4 on depression in van older Korean population

J.M. Kim, I.S. Shin, J.S. Yoon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

143

P.1.055 Antidepressant-like effect of the new adeninederivative in the forced swimming test

O.Y. Ananyeva, N.V. Onishchenko, V.I. Petrov, A.A. Ozerov, M.S. Novikov

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

144

P.1.056 Modafinil combined with selective serotoninreuptake inhibitor at treatment initiation enhances the rate and degree of benefit in major depressive disorder

H.A. Hassman, S.J. Glass, A. Sciamanna, R.T. Ninan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

145

P.1.057 Characterization of the serotonin transporterand its modulation by antidepressants in peripheral blood lymphocytes

T. Barkant, D. Gurwitz, A. Weizman, M. Rehavi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

146

P.1.058 Hyperforin induces release of dopamine and serotonin from rat brain slices

M. Rehavi, N. Roz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

147

P.1.059 Subacute effects of sertraline on attentionaland executive functions in major depression

E.L. Constant, S. Adam, B. Gillain, X. Seront, R. Bruyer, A. Seghers

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

148

P.1.060 No correlation of depression and anxiety toplasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder

M.C. Hsiao, C.C. Hsiao, C.Y. Lia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

149

P.1.061 Effects of fluoxetine and mirtazapine on insulin secretion in βTC-6 cells

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

150

P.1.062 Reboxetine added to SSRI accelerates the improvement in depressed patients who failed to respond to SSRI alone

J. Jaracz, M. Chłopocka-Woxniak, J.K. Rybakowski

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

151

P.1.063 Discriminative stimulus properties of theantidepressant, reboxetine, in rats: Mediation by α1-adrenoceptors and substitution with the neurokinin (NK)1 antagonist, GR205, 171

A. Dekeyne, L. Iob, M.J. Millan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

152

P.1.064 Pharmacological treatment of acute mania across Europe: Baseline findings from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study

E. Vieta, J.M. Haro, J. Van Os, M. Lorenzo, I. Goetz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

153

P.1.065 Effect of combined treatment with imipramine and metyrapone in patients with drug-resistant ular depression - clinical and pharmacokinetic studies

Z. Rogóz, G. Skuza, J. Wójcikowski, W.A. Daniel, D. Dudek, A. Wróbel, A. Zięba

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

154

P.1.066 The interaction between selective sigmaligands and uncompetitive NMDA receptor antagonists in the forced swimming test in rats

G. Skuza, Z. Rogóż

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

155

P.1.067 Who are the patients on remission of depressive disorders? Preliminary results of French depression survey ECLAIR

A. Gerard, G. Goussiaume, V. Millet

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

156

P.1.066 Vagus nerve stimulation (VNS): An alternativefor maintenance ECT?

R. Sorel, R. Kölling, H. Buschman, H. The, H. van der Aa

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

157

P.1.069 Personality profiles of patients with complete remission versus partial remission of depressive disorder

A. Pelissolo, A. Gerard, G. Goussiaume, V. Millet

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

158

P.1.070 Illness concepts and adherence in theprophylaxis of bipolar disorder

W. Greil, N. Kleindiener

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

159

P.1.071 Which clinical and psychosocial factorspredictit response to prophylactic lithium in bipolar disorders?

N. Kleindienst, R.R. Enger, W. Greil

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

160

P.1.072 Driving performance, psychomotor performance and cognitive function in healthy subjects: A comparison of escitalopram versus mirtazapine and placebo

M. Wingen, H.F. Andersen, J. Bothmer, S. Langem, I. Ramaekers

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

161

P.1.073 What differences between GP and communityprivate psychiatrists in depression care?

I. Gasquet, S. Tardieu, A. Bottero, P. Blin, M. Bohbot, A. Gerard, T. Labarthe, F. Liard, T. Marquet, S. Goni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

162

P.1.074 Safety and tolerability of duloxetine

M.M. Wohlreich, D.K. Kajdasz, C.H. Mallinckrodt, J.G. Watkin, O.V Martynov

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

163

P.1.075 SSRI's therapy in depressive outpatients:Personality changes and predictors of response

S. Kertzman, L. Luthorovich, H. Grinspan, M. Birger, I. Reznik, B. Spivak, A. Weizman, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

164

P.1.076 Influence of immunotherapy with pegylatedinterferon-alpha on platelet monoamine oxidase activity in high-risk melanoma patients

D. Fekkes, A.R. van Goof, H.H. van Ojik, M. Bannink, R.G.H. Mulder, W.H.J. Kruit, A.M.M. Eggermont, G. Stoter

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

165

P.1.077 Escitalopram vs venlafaxine XR treatment ofmajor depressive disorder

S.A. Montgomery

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

166

P.1.078 Chronic imipramine treatment reversesolfactory bulbectomized-induced hyperactivity species in three rodent species

M. Roche, E. Shanahan, A. Harkin, I.R. Kelly

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

167

P.1.079 Data from the Vienna Transdanube Aging (VITA) Study do not support the concept of vascular depression

M.K. Rainer, H.A.M. Mucke, T. Kuselbauer, S. Weissgram, S. Iungwir, W. Krampla, K.H. Tragl, R. Fiecher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

168

P.1.080 Assessment of cerebral regions associatedwith sexual arousal in depressive women before and after antidepressant treatment by using BOLD-fMRI

L.C. Yang, M.S. Lee, L.S. Yoon, I.S. Shin, S.I. Eun

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

169

P.1.081 Vardenafil temporally improves erectilefunction and depression intensity in men with mild major depressive disorder and erectile dysfunction

R. Shabsigh, D. Bakish, I. Goldstein, F. Montorsi, K. Bangerter, M. Seger, R.C. Rosen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

170

P.1.082 Musical hallucinations in a patient with a left temporal lobe tumor who responded to paroxetine

N. tanriverdi, B. Atalay, S. Mercan, A. Aktaas, L. Ozluoglu, L. Zileli

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

171

P.1.088 Temperament and Character Inventory (TCl) in patients with major depressive disorder

F. Celikel, S. Kose, B. Cumurcu, C.R. Cloninger

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

172

P.1.084 Pharmacokinetics of lamotrigine and oxcarbazepine co-therapy

G.E. Evoniuk, J. Ascher, J. Theis, J. Sidhu, S. Job, J. Palmer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

173

P.1.085 Response to maintenance therapy based on history of previous lithium experience

A.H. Young, W. Paska, R.L. White, R. Leadbetter

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

174

P.1.086 Modafinil as antidepressant augmentation therapy in major depressive disorder

M.E. Thase, C. DeBattista, M. Fava

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

175

P.1.087 Effect of milnacipran and sortraline on theβ-adrenergic receptor responsiveness in the major depressive disorder

J.E. Park, J.C. Yang, S.W. Kim, Y.C. Kim, E.J. Kim, B.H. Ye

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

176

P.1.088 Comparative open-label trial of atypical neuroleptics in children and adolescents with bipolar disorder

J. Biederman, E. Mick

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

177

P.1.089 Treatment of preschoolers with bipolar disorder

J. Biederman, E. Mick

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

178

P.1.090 Effectiveness of risperidone for the treatment of ADHD in children and adolescents with bipolar disorder

E. Mick, I. Biederman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

179

P.1.091 Influence of the serotonergic gene polymorphism on clinical response and adverse effects of paroxetine in Japanese depressive patients

G. Hirokane, S. Morita, M. Ueda, M. Okawa, K. Shimoda

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

180

P.1.092 Evaluation of psychiatric side effects ofinterferon-alpha treatment

A. Kovacs, G. Gazdag, Z. Battyanyi, A. Szomor, I. Buzogany, L. Par

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

181

P.1.093 The use of the PHQ as follow-up instrument for MDD in the primary care setting

K. Demyttenaere, W. Pitchot, A. Albert, D. Wagemane, P. De Cock

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

182

P.1.094 Reduction of the brain 123I-ADAM binding isrelated to the plasma drug level in amitriptyline treated subjects

R. Uebelhack, L. Franke, M. Piotkin, H. Amthauer, R. Felix.

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

183

P.1.095 Unipolar and bipolar depression: Demographic and clinical differences. Results from a European multicenter study

P. Oswaki, D. Souery, S. Kasper, Y. Lecrubier, I. Zohar, I. Mendlemicz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

184

P.1.096 Correlation of changes in electrical brain activity with changes in Hamilton depression rating scale after daily application of hypericum extract for six weeks in depressive patients

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

185

P.1.097 Pindolol augmentation of paroxetine in depressive patients: Sub-group analyses show benefits for bipolar and first-episode patients

W. Bitterlich, C. Geretsegger, W. Aichhorn, C. Stuppaeck, B. Bondy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

186

P.1.098 Is the hypomania checklist suitable forscreening bipolar II disorder?

I. Anest, E.G. Hantouche, H.S. Aldskal, S. Lancrenon, L. Chatenet-Duchene, D.A. Gérerd

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

187

P.1.099 Intracellular CAMP levels regulate the accumulation of lithium in neuronal cells

L.P. Montezinho, C.B. Duarte, C.P. Foneeca, C.F.G. Geraldes, A. Castro

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

188

P.1.100 The effectiveness and acceptability of mirtazapine and venlafaxine in general hospital out-patients with persistent depression. A naturalistic study

V. Vounatsi, P. Kanellos, I. Kogeorgos, I. Ioannidis

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

189

P.1.101 Oxidative stress and depression: Neurophysiological and biochemical correlations

M. Fomana, M.G. Heaoqua, P.L. Zuppi, R. Squitti, E. Tecchio, C. Saluetri, E. Zappesodi, P.M. Rossini

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

190

P.1.102 The relationship of the brain metabolism and the duration of illness in patients with major depressive disorder: Preliminary study

Y.Y. Nam, C.H. Kim, S.K. Lee, W.T. Jeon, E.J. Shin, H.S. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

191

P.1.103 Comparative efficacy of sertraline versusvenlafaxine-XR in severe depression

T. George, S. Uguz, M. Hopwood, R.D. Souza, A. Sir, E. Malout, T. Bure

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 97 KB

english, 2004

192

P.1.104 [1231]ADAM: A novel SPECT ligand for quantification of serotonin transporters in humans

N. Kleiu, J. Sacher, S. Asenbaurr, C. Pötzi, N. Mossaheb, T. Attarbasch, G. Dobrozemsky, R. Lanzenberger, G. Wiesegger, T. Geiss-Granadia, , R. Dudczak, S. Kasperl, J. Tauscher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 97 KB

english, 2004

193

P.1.105 Association between depression and elevatedC-reactive protein in a large community study; the significance of confounding factors

O. Bjerkeset, K. Hveem

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

194

P.1.106 Pharmacokinetic variations of mirtazapine in patients treated for major depression during six months

M. Reis, J. Proohazka, F. Hengtson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

195

P.1.107 Influence of pharmacotherapy on fas-receptorsand spontaneous apoptosis of lymphocytes in patients with depressive disorders

S.A. Ivanova, T.P. Vetlugina, V.Y. Semke, N.M. Rakihna, E.J. Chernyh, G.G. Simutkin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

196

P.1.108 Immunotropic influence of acute or chronic administration of Nootrop on the function of the GABA-ergic system in patients with major depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

197

P.1.109 The effect of antidepressant treatment onN-acetyl aspartate levels in the left anterior cingulate cortex of depressed patient: An MRS study

E. Ozan, O. Kitis, A.S. Gonul, E. Akdeniz, S. Vahip

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

198

P.1.110 The effects of chronic fluoxetine, olanzapine or olanzapine-fluoxetine combination treatment on the expression of brain derived neurotrophic factor levels in chronically stressed rats

E.O. Donat, O. Gozen, A.S. Gonul, E. Koylu, C. Eker, F. Akleniz, S. Vahip, S. Pogan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

199

P.1.111 The antidepressant effect of running isassociated with increased hippocampal cell proliferation

A. Pjerntbtkk, A.A. Mathé, S. Drtné

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

200

P.1.112 Correlation of depression ratings andremission cut-off scores on HAMD-17 and MADRS in double-blind, randomized comparisons of mirtazapine and SSRls

A. Heukels, A.J. Schutt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

201

P.1.113 Behavioural profiles of H/Rouenand NH/Rouen mice in different tests evaluating anxiety

M. El Yacoubi, J. Blot, J. González, J. Costenn, J.M. Vaugeois

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

202

P.1.115 Changes in regional α-[11C]methyl-L-tryptophan trapping in patients with major depression treated with citalopram augmented with pindolol

A. Berney, M. Nishilawa, G. Gobbi, P. Grevel, G. Debonnel, M. Diksic, C. Benlreifa

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

203

P.1.116 Antidepressant-like effects of citalogoam, antagoniste and amodel of receptor antagonist in an animal model of depression

D.H. Overetreet, A. Morkk, J.P. Redrobe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 222 KB

english, 2004

204

P.1.117 Serotonin and the 5HTlAreceptor in the signalling of taste: A novel human surrogate marker?

J.K. Meliohar, T. Htath, L.N. Jackson, H. Watson, D.J. Nutt, L.F. Donaldson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

205

P.1.118 Therapeutic application of right prefrontal lowrepetitive transcranial magnetic stimulation on depressed patients

S. Fuch, I. Reggere, F. Pinto, G. Scantamburlo, W. Pitchot, M. Hansenne, A. Maertens de Noorhout, M. Ansseau

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

206

P.1.119 Change in plasma levels of tumor necrosisfactor-α and acute phase proteins in depressive women during citalopram treatment

N. Tanriverdi, V. Tuzer, C. Duru, G. Ozcurumez, F. Kocer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

207

P.1.120 Effects of Mice daily 3 h maternal separations on behaviour, plasma corticosterone and brain monoamines in adult female rats

L. Arborelius, M. Eklund

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 123 KB

english, 2004

208

P.1.121 Venlafaxine XR in depressed and anxiouspatients with multiple, unexplained somatic symptoms in primary care

I. Benattia, I. Musgnung, I. Graepel

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

209

P.1.122 Development of depression, immune andendocrine markers during PEG-interferon-alpha therapy in chronic hepatitis C

A.W. Minderhout, J.P. Maes, S. Bourgeois, W. Uyttenbroeck, H. Neels, L. Vansweefelt, E. Sleuwaegen, J. Hulselmans

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

210

P.1.123 Venlafaxine XR and paroxetine in depressed outpatients: A comparison of clinical acceptability

A. Mignon, S. Leyman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

211

P.1.124 Gender-related differences of brain function inmajor depression — an fMRI-study applying a basal perception paradigms

T. Sobanski, G. Wagner, G. Sofianos, E. Straube, H. Sauer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

212

P.1.125 Study of the left hippocampus with in vivo NMR spectroscopy in patients with depressive disorders and subjective complaints about their memory efficiency

J.P. Papatriantafyllou, E.G. Gotsis, P. Toulas, V. Kontoyanni, J. Kapsalakis, T. Viviki, N. Tsinia, E. Pitsiava, P. Zikos, C. Karageorgiou

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

213

P.1.126 Changes in brain function associated withclinical response to duloxetine

A.F. Leuchter, I.A. Cook, M. Morgan, M. Abrams, C. McGrouther

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

214

P.1.127 Evidence for antidepressant- and anxiolytic-like activities of melatonin and agomelatine in animal models

P. Gruca, E. Przegalisnki, S. Mrowiec, M. Lason, M. Papp

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

215

P.1.128 Depressive symptoms and suicidal ideationamong college students: A study of 752 students in the Boston area

S.B. Sonawalla, E. Beaumont, Y. Mahal, D. Iosifescu, D. Mischoulon, J.E. Alpert, M. Fava

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

216

P.1.129 Depression and suicidal ideation among college students in Bombay: A study of 1357 individuals

R.M. Parikh, S.B. Sonawalla, M. Fava, N. Chakraborthy, G. Mehra, S. Dracass

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

217

P.1.130 Interactions between estrogen, scopolamine and venlafaxine in their influence on spatial memory in ovariectomized rats

K. Kus, E. Nowakowska, M. Łukaszemicz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

218

P.1.131 Adherence and tolerability of antidepressant-induced sexual dysfunction in depression-remitted Taiwanese patients: Gender difference

C.-F. Hung, J.-K. Wen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 222 KB

english, 2004

219

P.1.132 Polarity of the first episode and delay of the correct diagnosis of bipolar disorders

J.H. Kim, B.S. Cha, K.S. Ha

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

220

P.2.000 Dichotomy of clopamine transporter regulationby dopamine D2 receptors

F.J.S. Lee, A. Moszczynska-Mirecki, L. Pei, F. Liu

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

221

P.2.001 Serum homocysteine, folate level and MTHFR 677, 1298 polymorphism in schizophrenia

C. Na, Y.S. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

222

P.2.002 Pharmacoeconomic evaluation of relapse and re-hospitalization in patients with major depression treated with atypical antipsychotics

M.H. Snaterse, R.P. Welch

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

223

P.2.003 Tryptophan hydroxylase gene polymorphism (A218C) in homicidal schizophrenics

I.S. Chee, S.W Lee, J.L. Kim, S.K. Wang, Y.O. Shin, I.W. Chung, H.J. Ko

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

224

P.2.004 Statistical models for population heterogeneityin epidemiological longitudinal studies: Person-centred latent class analysis to identity casemix groups in the Turkish schizophrenia outpatient health outcomes study

M. Saylan, O. Karamustafalioglu, H. Özbay, M.E. Ceylan, E. Tetik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

225

P.2.005 Pharmacokinetics of the long-acting injectable form of risperidone: Evidence from a routine therapeutic drug monitoring service

I. Castberg, O. Spigset

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

226

P.2.006 Risk of diabetes, hyperlipidemia, andhypertension and the use of atypical antipsychotics in schizophrenia

R.M. Damler, Z.Y. Zhao, E.A. Jackson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

227

P.2.007 Antipsychotic treatment and diabetes in aprivately insured population

Z.Y. Zhao, D.L. Loosbrock, L.M. Cooper

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

228

P2.008 The effects of milnacipran on sleep indepressed patients: A polygraphic study with additional subjective assessment

P. Lemoine, J. Mouret

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

229

P.2.009 Serum interleukin 6 and 8 levels inschizophrenia

A. Turkoglu, T. Okay, A.C. Sengul, G. Bayam, N. Dilbaz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

230

P.2.010 Seizure duration with clozapine and olanzapine in electro convulsive therapy

A.C. Sengul, A. Turkoglu, T. Okay, G. Bayam, N. Dilbaz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

231

P.2.011 Factors related to weight gain in patients withschizophrenia treated with serotonin-dopamine antagonists

W.S.J. Jang, S.K.K. Kim, K.S.C. Choi, D.Y.P. Park, W.S.H. Han, K.S.H. Hong, D.S.L. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

232

P.2.012 Metabolic syndrome in patients withschizophrenia

G. Pandina, I. Turkoz, A. Greenspan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

233

P.2.013 Anti-saccadic inhibition errors in patientswith borderline personality disorder and psychotic-like symptoms

K.P. Grootens, R.J. Verkes, J.W. Hummelen, S.A. van der Laan, G. van Luijtelaar

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 225 KB

english, 2004

234

P.2.014 Medication specific correlates of relapse risk in schizophrenia

J. Peuskens, W. Deberdt, D. van Brunt, A. Hill, H. Liu Seifen, J. Csernansky, P. Buckley

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

235

P.2.015 Olanzapine versus risper idone in the treatment of bipolar I disorder: Determinants of change in severity of bipolar illness ratings

E.B. Brown, S. Ahmed, L.M. Schuh, R.W. Baker

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

236

P.2.016 Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomised controlled study

R. Newton, S.M. Evans, S. Higgins

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

237

P.2.017 An investigation of some brain regions withproton magnetic resonance spectroscopy (1H-MRS) method in patients with first-episode and chronic schizophrenics

M. Cetin, S. Ebrinc, H. Kandilcioglu, C. Basoglu, U.S. Basar, E. Silit, E. Kizilkaya, H. Gunay, M.S. Iyisoy, M. Cetin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

238

P.2.018 Classical neuroleptics do not change the membrane phospholipase D activity

M. Krzystanek, I. Krupka-Matuszczyk, H.I. Trzeciak, E. Krzystanek

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

239

P.2.019 The effects expression regional c-Fosprotein expression in the rat forebrain

J.E. Cluderay, S.L. Simonini, J. Cilia, C.A. Jenings, M.M. Kalinichev, A. Lloyd, D.N.C. Jones, E. Southam

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

240

P.2.020 Altered profiles of novelty seeking andimpulsive behaviour in rats exposed to neonatal asphyxia: Interaction with environmental enrichment

W. Adriani, D. Giannakopoulou, G. Laviola

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

241

P.2.022 Quality of life of schizophrenic patientsmeasured with WHOQOL Bref — Polish version

K. Jaracz, K. Gorna

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

242

P.2.023 Objective and subjective quality of life in schizophrenic patients after a first hospitalization

K. Gorna, K. Jaracz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

243

P.2.024 Predictors of social functioning in first-episodeschizophrenia — 1 year follow-up

K. Gorna, F.J. Rybakowski, K. Jaracz, J.K. Rybakowski

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

244

P.2.025 The efficacy of combined therapy of clozapineand haloperidol in the treatment-resistant schizophrenic patients

D. Ignjatovic Ristic, G. Mihajlovic, D. Djokovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

245

P.2.026 Glucose and cholesterol level changes in patients treated with atypical ion therapy and or valproic acid combination therapy

D.B. Park, D.H. Han, B.S. Kee, C.H. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

246

P.2.027 The use of antipsychotics as treatment for anorexia nervosa: Observational study of patients treated with amisulpride

J.L. Rodriguez-Calvin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

247

P.2.928 Investigating the association betweenneuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 and D3 receptor gene

I. Kishida, C. Kawanishi, T. Furuno, D. Kato, Y. Hirayasu

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

248

P.2.029 Quetiapine: Broad-based efficacy in borderline personality disorder

É. Villeneuve, S. Lemelin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

249

P.2.030 The comparison of risperidone, olanzapineand quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder

L.G. Kim, D.H. Cho, H.K. Choi, H.H. Kim, J.H. Cho, S.H. Kang, S.I. Lee, I.G. Lee, H.T. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

250

P.2.031 Quetiapine: Placebo-level prolactin and lowlevels of sexual dysfunction

J. Bobes, K. Timdahl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

251

P.2.032 Drug monitoring factors in schizophrenia treatment

D. Vasile, M.D. Gheorghe, O. Vasiliu, S. Paraschiv

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

252

P.2.033 Treatment of suicidal risks in schizophrenia with atypical antipsychotics

I.T. Timotijevic, L.S. Stefanovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

253

P.2.034 Predictors of treatment outcome in schizophrenia — 1-year follow-up study of first-admitted patients

F.J. Rybakowski, K. Gorna, K. Jaracz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

254

P.2.035 Inward rectifying potassium channel(hSKCA3) gene and cognitive disturbances in schizophrenia

M. Ivkovic, A. Damjanovic, V.R. Paunovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

255

P.2.036 Use of mood stabilizers in patients with schizophrenia 1999–2004

N. Divac, A. Vujovic, K. Savic, I. Timotijevic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

256

P.2.037 Reducing long term physical health risks associated with severe mental illness through a weight management programme: 3 year results

I. Pendlebury, I. Malone, S.D. Soni, P.M. Haddad, S. Dursun

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

257

P.2.038 Prepulse inhibition and its attentionalmodulation in the human tryptamine and ketamine models of psychosis

K. Heekeren, A. Timmerbeil, M. Stoll, C. Stock, E. Gouzoulis-Mayfrank

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

258

P.2.039 Prolactin screening in a prospective naturalisticcohort of schizophrenia outpatients in United Kingdom

M. Shaw, A. Banymandhub, C.J. Bushe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

259

P.2.040 Change of cognitive functions in switching ofrisperidone for chronic schizophrenic patients

J.H. Choi, M.Y. Jung, H.G. Lung, T.Y. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

260

P.2.041 Glucose changes during prospective clinicaltrials of olanzapine and aripiprazole

R.I.G. Holt, C.J. Bushe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

261

P.2.042 What can placebo clinical trial cohort datatellabout the relationship between schizophrenia and diabetes?

C.J. Bushe, R.I.G. Holt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

262

P.2.043 A new competitive ligand of 5-HT3 receptors

B. Vitalis, V. Csillik-Perczell, G. Matel, D. Barlocco

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 217 KB

english, 2004

263

P.2.044 Dysfunctional supplementary motor area implication during attention and time estimation tasks in neuroleptic naïve schizophrenia

F. Ortuño, P. Molero, J. Pla, M. Rapado, C. Soutullo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 102 KB

english, 2004

264

P.2.045 The association of 5HT6(C267T) genetic polymorphism on the antidyskinetic effect of risperidone among schizophrenic patients

J.Y. Chen, Y.J. Liou, Y.M. Bai, C.C. Lin, Y.C. Wang

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 102 KB

english, 2004

265

P.2.046 Menstrual irregularities in first-episodepsychosis: A pilot-study

N.P. Maric, M. Jasovic-Gasic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 206 KB

english, 2004

266

P.2.047 Shared decision making on antipsychotic drug choice for inpatients with schizophrenia

I. Hamann, V. Winkler, S. Leucht, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

267

P.2.040 Course and stability of psychomotor functionsrelated to car driving skills in schizophrenic patients: A pilot study

E. Geiger, A. Brunnauer, G. Laux

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 216 KB

english, 2004

268

P.2.049 Clinical use of annisulpride in people over 65 years old

J.M. Pascual-Paño

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

269

P.2.050 The effect ofneuroleptic medication on brain metabolite measures in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS) study

A. Szulc, B. Galinska, E. Tarasow, J. Walecki, A. Czernikiewicz, W. Dzienis, B. Kubas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

270

P.2.051 Impact of the treatment with amisulpride inpatients with schizophrenia and schizophrenic mood disorder

G. Medina Ojeda, J.I. Franch Valverde, J.A. Blanco Garrote

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

271

P.2.052 Electroencephalographic changes in chronic neuroleptic-resistant schizophrenia patients during clozapine treatment

S. Kertzman, B. Spivak, I. Blatt, M. Vainder, A. Weizman, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

272

P.2.053 Weight gain in Korean schizophreniainpatients: A comparison of risperidone and olanzapine

H. Kim, K.J. Lee, S.H. Lee, Y.C. Chung

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

273

P.2.054 The clinical status of neuroleptic naive patientswith schizophrenia following monotherapy with olanzapine, risperidone or typical antipsychotics: A 12-month analysis

T. Treuer, G. Gál, L. Raducan, S. Rudzianskiene, A. Szulc, J. Pecenak, D. Logozar Perkovic, J. Leadbetter, J. O'Mahoney

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 218 KB

english, 2004

274

P.2.055 Subjective well-being under neuroleptictreatment: Comparison of atypical versus typical antipsychotic 12-months monotherapy treatment in the SOHO Study

D. Naber, M. Lambert, F. Roesch, A. Ritzhaupt, A. Horn, I. Czekalla

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

275

P.2.056 Antipsychotic polypharmacy in Germanyand Europe — results from a schizophrenia outpatient treatment observation study (SOHO)

M. Lambert, I. Czekalla, F. Langer, T. Wagner, A. Horn, D. Naher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 215 KB

english, 2004

276

P.2.057 Atypical antipsychotics, prolactin, cholesteroland bone mineral density in patients with chronic schizophrenia — a preliminary report

S.H. Won, K.P. Kwak, H.D. Yun, B.J. Kang, I.H. Shin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

277

P.2.058 Habenula lesion causes attention deficitsin rats: implications for cognition and schizophrenia

L. Lecourtier, P.H. Kelly

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 216 KB

english, 2004

278

P.2.059 Catechol-O-methyltransferase genepolymorphism in symptomatology of schizophrenia

C.T. Lee, H.K. Lee, Y.S. Kwon, K.U. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

279

P.2.060 The efficacy of risperidone in the managementof attempted suicide in patients with schizophrenia

Y. Barak, H.Y. Knobler, I. Mirecki, D. Aizenberg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

280

P.2.061 Long-term weight effects of aripiprazole and olanzapine: Results from a 26-week double-blind comparison study

W. Carson, R. McQuade, N. Abou-Gharbia, T. Iwamoto, D. Archibald, E. Stock

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

281

P.2.062 The short-term effect of orally disintegrating olanzapine tablets on agitation and cooperation in clinical practice

C. van Heeringen, B. Gillain, B. van Vleymen, E. van den Driessche

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

282

P.2.063 Pharmacological characterisation of SR 142801(osanetant) at clonal and native NK-3 receptors

D.R. Thomas, N. Patel, L.A. Dawson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

283

P.2.064 A dose-ranging study of aripiprazole treatment in patients with psychosis associated with Alzheimer's dementia

D. Kostic, C. Breder, R. Swanink, R. Marcus, T. Iwamoto, W. Carson, R. McQuade

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

284

P.2.065 Does improvement in psychopathologycorrelate with improvement in health related quality of life? Results from the SQUARE study

A. Christodoulopoulou, A. Karokis, J. Yfantopoulos, V. Papagiannopoulou, A. Karavatos, N. Angelopoulos, F. Gourzis, J. Stathakis, M. Tzanakaki, P. Panagoutsos, V. Mavreas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

285

P.2.066 Intramuscular aripiprazole treatment for acute agitation in patients with psychosis

R. Gismondi, D. Daniel, F. Stock, R. Wilber, R. Marcus, W. Carson, G. Manos, T. Iwamoto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

286

P.2.067 Long-term effects of aripiprazole on affective symptoms of schizophrenia

J. Octavio, E. Stock, D. Archibald, S. Tourkodimitris, M. Kujawa, R. Marcus, W. Carson, T. Iwamoto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

287

P.2.068 Involvement of the val/met polymorfism ofthe cathecol-o-methyltransferase gene in schizophrenia and schizophrenia spectrum diseases

P.M.S.P. Molero, F.O.S.F. Ortuno, C.S.E.C. Soutullo, A.P.G.A. Patino

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 214 KB

english, 2004

288

P.2.069 Smooth pursuit eye movements inschizophrenic patients treated with clozapine or flupentixol and the relationship to cognitive performance

H.J. Schewe, D. Rufer, R. Bachus, R. Uebelhack

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 216 KB

english, 2004

289

P.2.070 Patients with psychosis on conventional depotneuroleptics benefit from a treatment change to risperidone long-acting injectable

R. Hoekstra, R. Teijeiro, A. Lex, V. Curtis

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

290

P.2.071 Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice

S. Beraki, F. Aronsson, H. Karlsson, S.O. Øgren, K. Kristensson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

291

P.2.072 Aripiprazole treatment for acute mania in patients with bipolar I disorder: A placebo-controlled study

H. Grunze, W. Carson, G. Sachet, R. Sanchez, R. Marcus, M. Kujawa, D. Archibald, T. Iwamoto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

292

P.2.073 The effect of MK-801 on the phosphorylationof GSK-3 beta in the rat frontal cortex

Y.S. Kim, Y.S. Juhnn, Y.M. Ahn, M.S. Seo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

293

P.2.074 Is substance use high among patients withschizophrenia in Turkey?

Y. Akvardar, M.N. Tümüklü, B.B. Akdede, H. Ulaş, K. Alptekin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

294

P.2.075 The histamine 111 receptor gene polymorphicvariants and schizophrenia

B. Godlewska, J. Limon, M. Chmara, J. Landowski

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

295

P.2.076 Efficacy of aripiprazole and perphenazine in severe schizophrenia resistant to treatment with atypical antipsychotics

S. Modell, D. Jody, M. Kujawa, W. Carson, J. Stringfellow, T. Jwamotob, R. Marcus, E. Stock

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

296

P.2.077 Long-term clinical effectiveness of quetiapine in first-episode psychosis

L. Kopala, H. Milliken, D. Whitehorn, Q. Rui, H. Woodley, K.P. Good

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

297

P.2.078 New insights in the therapeutic adherence in schizophrenia

J. Giner, M. Roca, F. Cañas, A. Rodríguez, J.M. Olivares, A. Rodríguez-Morales, J.A. Burón, G. Martinez-Junquera

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

298

P.2.079 Evaluation of the relationship between antipsychotics and hospitalization in bipolar disorder

C. Kozma, M.F.T. Rupnow

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

299

P.2.080 Brief psychosis: A classical category with a distinct serotonergic profile

B. Arranz, N. Ramirez, J.M. Sanchez, M.R. Dueñas, P. Fernandez, E. Alvarez, V. Perez, L. San

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

300

P.2.081 Reversible accumbens hypometabolism in a case of akinetic catatonia

L. Joly, X. De Tiege, S. Goldman, J. Mendlemicz, J. Massat

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

301

P.2.082 Neuromuscular dysfunction in neuroleptics-treatedpsychiatric patients

I. Reznik, L. Uolchek, M. Reznik, M. Kotler, A. Weizman, H.Y. Meltzer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

302

P.2.083 Suicide attempts in familial schizophrenia

O. Zivanovic, L.J. Borisev

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

303

P.2.084 Switching patients with schizophrenia andantipsychotic-related metabolic disturbances to ziprasidone

J.M. Montes, P. Sopelana, E. Martín, E. Jaén, J.A. Soto, M. Sanz, J.L. Rodríguez, A. Balbo, J. Delgado

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

304

P.2.085 Ziprasidone: Long-term post-switch efficacy in schizophrenia

J. Dunn, G.M. Simpson, M. Fayek, P.J. Weiden, S. Murray, L. Warrington, A. Loebel

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 218 KB

english, 2004

305

P.2.086 Amisulpride in clozapine-resistant schizophrenia

V.P. Kontaxakis, B.J. Havaki-Kontaxaki, K.G. Paplos, P.P. Ferentinos, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

306

P.2.087 Treatment of psychotic symptoms in childrenand adolescents with bipolar disorder

E. Mick, J. Biederman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

307

P.2.088 Concurrent use of clozapine and ECT as anaugmentation strategy in clozapine-resistant schizophrenic patients

B.J. Havaki-Kontaxaki, P.P. Ferentinos, V.P. Kontaxakis, K.G. Peplos, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

308

P2.089 An observational study (IC-SOHO) comparingolanzapine, risperidone, quetiapine, and haloperidol in the treatment of patients with schizophrenia: 12-Month results

T. Treuer, R. Bartiene, M. Blinc-Pesek, A. Grigoriu, E. Herman, H. Molnár, I. Pecenak, T. Shakhnovich, A. Szulc, J. Leadbetter, J. O'Mahoney

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 217 KB

english, 2004

309

P.2.090 The possible role of the D3 dopamine receptorin rat model of tardive dyskinesia

H. Rosengarten, M. Healy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 102 KB

english, 2004

310

P.2.091 No association of the LIP gene withschizophrenia in the Korean population

T.Y. Jun, K.U. Lee, H.K. Lee, Y.S. Kweon, J.T. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 102 KB

english, 2004

311

P2.092 Sexual dysfunction associated withantipsychotic treatment for schizophrenia: Results from the first 12 months of the Intercontinental Schizophrenia Outpatients Health Outcomes (IC-SOHO) study

C.Y. Kim, C.E. Kim, C.C. Hsiao, S.C. Ree, S. Singh, A. Hodge, A.J. Lowry, P.P. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

312

P.2.093 Bioequivalence of an orally disintegrating tablet compared to the oral tablet formulation of the antipsychotic aripiprazole

K. Scott, D. Boulton, D. Dressler, G. Kollia, N. Vachharajani, S. Mallikaarju, W. Carson, D. Kornhauser

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

313

P.2.094 Risperidone reduces symptoms of psychosisin Alzheimer's Disease: Results from 3 double-blind controlled clinical trials

P.P. De Deyn, A. Greenspan, B. Lyons, H. Brodaty

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

314

P2.095 Risperidone in children with disruptive behavior disorders: A 2-year open-label trial

M. Reyes-Harde, J. Croonenberghs, M. Eerdekens

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

315

P.2.096Atypical antipsychotics and driving-related psychomotor skills in schizophrenic patents

A. Brunnauer, E. Geiger, G. Laux

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 213 KB

english, 2004

316

P.2.097 The risk of new-onset type 2 diabetesand coronary heart disease in chronic schizophrenic patients treated with aripiprazole and olanzapine

L. Blonde, S. Ray, P.K. Corey-Lisle, R.R. Cislo, G. L'Italien

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

317

P.2.098 EEG abnormalities in patients treated with quetiapine

D. Degner, E. Rüther, R. Akkan, S. Bleich

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 104 KB

english, 2004

318

P2.099 Neurological soft signs, extrapyramidal signs,spontaneous dyskinesia and SPECT findings in never-medicated patients with schizophrenia: A comparative study

C. Aydemir, E. Goka, C. Kisa, A. Kurt, S. Naldoken, H. Ortapamuk

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

319

P.2.100 Phencyclidine (PCP) as a model for schizophrenia

J. Hinterhoelzl, K. Salimi, C. Humpel, C. Adlassnig, R. Fischer-Colbrie, W. Fleischhacker, I. Marksteiner

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

320

P2.101 Risperidone prevents relapses of disruptive behavioral disorders in children and adolescents of average intelligence: A 6-month trial of risperidone versus placebo

M. Reyes-Harde, J.K. Buitelaar, I. Augustyns, M. Eerdekens

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

321

P.2.102 The use of atypical antipsychotics inthe treatment-resistant combat-related posttraumatic stress disorder with psychotic features

N. Pivac, D. Kozaric-Kovacic, D. Mueck-Seler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

322

P.2.103 Calcium balance and regulation in patients with diagnosis of schizophrenia treated with second generation antipsychotics

A.W.K. WyszogrodzkaKucharska

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

323

P2.104 Efficacy and safety of risperidone in the treatment of children with autistic and other pervasive developmental disorders (PDD): A randomized, double-blind, placebo controlled trial

M. Light, F. Dunbar, S.E. Shea

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

324

P2.105 Clozapine but not haloperidol blocks thecognitive impairment and changes in emotional behaviour caused by repeated phencyclidine in mice

H. Bengtsson, A. Kuzmin, S.O. Ögren

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

325

P2.106 The effect of clozapine on factors controllingglucose homeostasis

O.D. Howes, A. Bhatnagar, F. Gaughran, S. Amiel, R.M. Murray, L.S. Pilowsky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

326

P.2.107 An economic evaluation of aripiprazole compared to olanzapine based on metabolic side-effect profile

S. Ray, P.K. Correy-Lisle, P.K. Cislo, G. L'Italien, P. Weiden

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

327

P.2.100 Topiramate as add-on therapy in chronicschizophrenia

F. Pieraccini, I. Soreca, P. Castrogiovanni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

328

P.2.109 Identification of determinants of treatmentresponse to amisulpride using multivariate regression analysis

Y. Lecrubier, C. Ponsard, W. Rein

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

329

P.2.112 Is quality management in schizophrenia outpatient care cost effective?

U. Seemann, C. Schwarz, B. Janssen, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

330

P.2.113 Artificial neural network prediction oftherapeutic response to clozapine with clinical and genetic factors

C.C. Lin, Y.M. Bai, Y.C. Wang, J.Y. Chen, Y.I. Liou, C.Y. Lin, C.M. Chueh

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

331

P.2.114 A prospective observational study of the effectiveness and tolerability of amisulpride in an international sample of patients with schizophrenia

M. Lindem, M. Davidson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

332

P.2.115 The schizophrenia quality of life scale (SOL)42-item short form (SOL-42): Conceptual framework and item selection

P. Martin, C.S. Peretti, J. Dalery, J.M. Azorin, M.C. Hardy-Bayleb, D. Etiennes, C. Gury, D.A. Gérard

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

333

P.2.117 Psychopharmacological management of acutepsychosis in the psychiatric intensive care unitof the Medical University of Vienna

A. Heiden, R. Wimmer, R. Frey, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

334

P.2.117 Psychopharmacological management of acutepsychosis in the psychiatric intensive care unitof the Medical University of Vienna

A. Heiden, R. Wimmer, R. Frey, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

335

P.2.118 Metabolic control in patients with comorbidschizophrenia and depression treated with amisulpride or olanzapine

J.M. Vanelle, S. Douki

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

336

P.2.119 A placebo-controlled double-blind investigationof cognitive effects of rivastigmine in Schizophrenia

T. Sharma, C. Hughes, V. Kumari, I. Aasen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

337

P.2.120 Psychosocial skills and clinical statusassociated with quality of life in a cohort of French schizophrenic patients

J. Dalery, P. Martin, C.S. Peretti, J.M. Azorin, M.C. Hardy-Bayle, D. Etienne, C. Gury, D.A. Gésard

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

338

P.2.121 Assessing executive functioning in schizophrenia with the Cogtest

L. Maron, W. Perry, R. Bilder, T. Sharma

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

339

P.2.122 Comparison of quetiapine, olanzapine, andrisperidone in schizophrenia

E. Sacchetti, P. Valsecchi, C. Regini, A. Galluzzo, P. Cacciani, E. Agrimi, C. Mencacci

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

340

P.2.123 Investigator's assessment questionnaire(IAQ): A new clinician-administered scale for measuring overall antipsychotic effectiveness

G. L'Italien, J. Han, H. Li, S. Ray, W. Carson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

341

P.2.124 Neural correlates of rivastigmine treatment in schizophrenia: An fMRI study

V. Kumari, I. Aaeen, T. Sharma

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

342

P.2.125 The effects of aripiprazole on the cognitive symptoms of schizophrenia

J.Y. Loze, D. Kostic, R. McQuade, S. Hardy, W. Carson, T. Iwamoto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

343

P.2.126 Pharmacological evaluation of D2 partial agonists: Coupling D2 RS to Gαq/o and Gαq/i chimeras in CHO-K1 cells

J. Heinrich, M. Lai, M. Popiolek, X. Bang, M. Pausch, H. Mazandarani, T. Wasik, G. Stack, K. Marquis, T. Andree

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

344

P.2.127 An anti-stigma project for students: Increasingthe knowledge about schizophrenia and reducing psychiatric stigma

K. Wundsam, G. Pitschel-Walz, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

345

P.2.128 48-week outcomes for patients who switched from prior single and multiple antipsychotic medications to olanzapine treatment: A 24 week open label multi-center study with 48 week follow up

Y. Fujii, G.A. Gerstenberg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

346

P.2.129 Safety and toleraty of anti psychotics inchildren and adolescents: Preliminary results of a longitudinal study

P. Laita, C. Arango, A. Doll

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

347

P.2.139 Antipsychotic treatment adherence andviolence in schizophrenia outpatients: A randomized prospective trial

I. Bombin, C. Arango

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

348

P.2.131 Quetiapine: Placebo-level extrapyramidal symptoms including akathisia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

349

P.2.133 Effects of aripiprazole on the steady-statepharmacokinetics of valporic acid

D. Boulton, T. Vanderslice, D. Kornhauser, M. Geraldes, G. Kolia, N. Vaccharajani

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

350

P.2.134 Depressive response to antipsychotics

S. Kesebir, S. Pirildar

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

351

P.2.135 Neurohypophyseal responose to apomorphineand clonidine stimulation in major depression

G. Scantamburlo, M. Hansenne, S. Fuchs, W. Pitchot, E. Pinto, I. Reggers, M. Ansseau, J.J. Legros

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

352

P.2.136 The effects of zotepine in treating psychoticpatients with hyperuricemia: A case series

T.T. Chen, J.Y. Chen, Y.M. Bai, C.C. Lin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

353

P.2.137 Can the PANSS cognitive factor be a validsurrogate for neurocognon in schizophrenia?

G. Sethuraman, S. Ahmed, S.L. Rock, C.A. Young, E.M. Marquez, S.E. Purdon, R.S.E. Keefe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

354

P.2.138 Prevalence of comorbidities in ambulatoryschizophrenic patients treated with antipsychotics

E. Baca, M. Roca, C. Varela

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

355

P.2.139 Impact of CYP1A2 and 2D6 pingeneticpolymorphisms on clozapine and olanzapine metabolism at steady-state

M.G. Scordo, A. Gunes, K.I. Melkersson, M.L. Dahl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

356

P.2.140 Cognitive improvement andneuropsychological normalization with ziprasidone or olanzapine: Results of a 6-month study

P.D. Harvey, C.R. Bowe, A. Loebel, L. Warrington

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

357

P.2.141Subjective quality of life and medication strategies in schizophrenia care

U. Seemann, C. Schwarz, B. Janssen, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

358

P.2.142 Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia: Prefrontal fast oscillations and WCST in patients with schizophrenia

I. Mazurek, M. Bartyzel, B. Loza, A. Mosiolek, G. Opielak

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

359

P.2.143 Does cannabis use affect endogenouscannabinoids in schizophrenia?

F.M. Leweke, A. Giuffrida, D. Koethe, D. Schreiber, C.W. Gerth, D. Piomelli, J. Klosterkötter

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

360

P.2.144 Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity: Implications for bipolar depression

K. Rasmussen, M.A. Seeger

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 94 KB

english, 2004

361

P.2.145 Olanzapine in adolescent and young adult patients with schizophrenia: Does subjective well-being improve?

R.W. Dittmann, U. Hagenah, J. Junghanß, J. Linde, A. Maestele, C. Mehler-Wex, E. Meyer, M. Pitzer, H. Remschmidt, D. Schlamp, M. Schulte-Markwort, E. Schulz, O. Weiffenbach

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 94 KB

english, 2004

362

P.2.146 Clozapine and haloperidol prevents altered cytoskeletal organization in a stress oxidative cell culture model

H.A. Ortega-Soto, L. Ortiz, O. Ramírez-Rodríguez, G. Benitez-King

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

363

P.2.147 Antipsychotic medication and treatment outcome in schizophrenia outpatient care

U. Seemann, C. Schwarz, B. Janssen, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

364

P.2.148 Electroencephalographic study of Neurocognitiveperformance in patients with paranoid schizophrenia

G. Opielak, M. Bartyzel, B. Loza, I. Mazurek, A. Mosiolek

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

365

P.2.149 Quantitative electroencephalogram (QEEG) ofneurocognitive performance in patients with paranoid schizophrenia

A. Moeiolek, M. Bartyzel, B. Loza, I. Mazurek, G. Opielak

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

366

P.2.150 Quetiapine reduces persistent anxiety in patients with major depressive disorder

S.D. Targum, H. Hassman, B. Bastani, M. Bari, L. Ramirez

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

367

P.2.152 Double-blind, placebo-controlled study ofquetiapine in bipolar I depression

W. Macfadden, J. Calabrese, R. McCoy, M. Minkwitz, E. Wilson, J. Mullen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

368

P.2.153 Double-blind,etiapine in bipolar depression

J.R. Calabrese, W. Macfadden, R. McCoy, M. Minkwitz, E. Wilson, J.. Mullen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

369

P.2.154 Number-needed-to-treat evaluation of controlled trials of olanzapine, quetiapine, or risperidone as adjunctive treatments for bipolar mania

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

370

P.2.155Tissue specific endocannabinoid dysregulation in a mouse model of hyperdopaminergia

E.T. Tzavara, D.L. Li, L.A. Phebus, C. Crozatier, G.G. Nomikos, B. Giros

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

371

P2.156 Neonatal handling attenuates the enhancementof immobility induced by subacute phencyclidine in the forced swimming test, a schizophrenia negative symptoms-like animal model

P. Tejedor-Real, M. Sahagun

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

372

P.2.157 Decreased platelet serotonin transporter inpatients with psychotic disorders

D. Marazziti, S. Baropi, B. Dell'Osso, I. Masala, L. Vivarelli, F. Mungai, G. Giannaccini, D. Marazziti

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 219 KB

english, 2004

373

P.2.158 Risperidone efficacy in cognitive disorderstreatment during the first relapse of schizoprenia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

374

P.2.159 Olanzapine in schizophrenic patients withcomorbid cannabis abuse

Z. Robone, V. Orlandi, G. Bersani

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

375

P.2.160 Blunted inhibition of return in humanhallucinogen models of psychosis

E. Gouzoulis-Mayfrank, K. Heekeren, A. Timmerbeil, M. Stoll, K. Stock

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

376

P.3.001 Escitalopram in the treatment of kleptomania

E.A. Aboujaoude, L.M. Koran, N. Gamet

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

377

P.3.002 Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study

N. Kocabasoglu, A. Çorapçrolu, I. Yargic, A. Erdogan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

378

P.3.003 A randomized, double-blind, 8-week comparison of venlafaxine XR and placebo in out-patients with Generalized Anxiety Disorder (GAD)

J. Kogeorgos, I. Nimatoudis, N. Zissis, S. Tsilikas, I. Charambopoulos, M. Zittis, Th. Moulatsiotis, A. Vidalis, G. Kaprinis

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

379

P.3.004 Tiagabine for posttraumatic stress disorder: Effects of open-label and double-blind discontinuation treatment

K. Connor, J. Davideon, R. Weieler, W. Zhang, K. Abraham, M. Darwish

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

380

P.3.005 Role of nitric oxide on chemically-induced defensive reactions in the dorsolateral periaqueductal grey

D.C. Aguiar, A.C. DeLucca, F.S. Guimaraes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

381

P.3.006 A double-blind, placebo-controlled trial ofvenlafaxine XR in the short-term treatment of panic disorder

M.R. Liebowitz, G. Asnis, E. Tzanis, T. Whitaker

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

382

P.3.007 Safety and efficacy of venlafaxine ER in the treatment of pediatric social anxiety disorder

M. Rynn, J. March, K. Tourian, R. Mangano

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

383

P.3.008 Treatment of trichotillomania with atypicalantipsychotics: A case series

A.V. Ravindran, V. Tram, M.A. van Ameringen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

384

P.3.009 A double-blind, placebo-controlled trial of folicacid addition in fluoxetine for treatment of obsessive-compulsive disorder

Ü. Tural, A. Çorapçiolu, Ş. Bo¢gelmez, G. Körolu, C. Duman, E. Önder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

385

P.3.010 Children and adolescents with social anxiety disorder: School refusal and improvement with venlafaxine ER relative to placebo

A.M. Albano, R. Mallick, K. Tourian, H.F. Zhang, C. Kearney

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

386

P.3.011 Correlation of HAM-A and PARS in pediatric generalized anxiety disorder

M. Rynn, R.R. Yeung, M. Riddle, N.R. Kunz, Y. Li

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

387

P.3.012 intra-dorsal raphe nucleus injection of the5-HT1 receptor antagonist WAY-100635 bits the panic-like behavior induced by chemical stimulation of the dorsal periaqueductal gray

H. Zangrossi, T.L. Borges

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

388

P.3.013 Sensitization of 5-HT1A and 5-HT2 receptors in the dorsal periaqueductal gray after long-term treatment with imipramine: Evidence from the elevated T-maze test of anxiety

H. Zangrossi, J.M. Zanoveli, R.L. Nogueira

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

389

P.3.014 A case-controlled study of delayed phase shift in inpatients with Obsessive Compulsive Disorder (OCD)

J. Turner, L.M. Drummond, N. Fineberg, S. Mukhopadhaya, H. Ghodse

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

390

P.3.015 Is generalized anxiety disorder a chronicdisorder? Predicting chronicity and spontaneous remission

K. Beesdo, H.U. Wittchen, M. Hoefler, H. Pfister, A. Bittner, R. Lieb

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

391

P.3.016 Paradoxal antipanic effect of α2-noradrenergic antagonism in Meriones unguiculatus (Rodentia, Gerbilinae) confronted with Boa constrictor amarali (Reptilia, Boidae)

R. Costa-Guimarãs, L. Pippa-Gadioli, T.T. Felippotti, W.A. Ubiali, T. Paschoalin-Maurin, A. Weltson, L.V. Rimi, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

392

P.3.017 Elevated premenstrual serum cholesterollevels in women with premenstrual dysphoric disorder

C.Y. Liu, M.C. Hsiao, C.C. Hsiw

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

393

P.3.018 Association between dopamine transporter and dopamine receptor D4 polymorphism and obsessive-compulsive disorder

C.H. Kim, S.J. Kin, H.S. Lee, J.S. Kwon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

394

P.3.019 Escitalopram and paroxetine compared toplacebo in the treatment of of Generalised Anxiety Disorder (GAD)

D.S. Baldwin, A.K.T. Huusom, E. Maehlum

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

395

P.3.020 A retrospective case note study of sleep inobsessive compulsive disorder

S. Mukhopadhyay, L.M. Drummond, N. Fineberg, J. Turner, H. Ghodse

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

396

P.3.021 Nocturnal panic: An underrecognized entity

U. Albert, G. Maina, C. Bergesio, F. Bogetto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

397

P.3.022 The efficacy of mirtazapine in socialanxiety disorder: A double-blind placebo controlled study with adjunctive paroxetime in nonresponders to treatment

S.I.J. Schutters, H.G.J. van Megen, H.G.M. Westenberg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

398

P.3.023 Quality of life in patients with Obsessive-compulsivedisorder: Relations with cognitive functions and clinical symptoms

B.B. Akdede, K. Alptekin, Y. Akvardar, A. Kitiş

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

399

P.3.024 Specificity/aspecificity of thepsychopathological dimensions of obsessive-compulsive disorder

M. Martinucci, A. Goracci, L. Guidelli, S. Roeei, A. Di Muro, P. Castrogiovanni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

400

P.3.025 Asthenia: A comparison between obsessive-compulsivedisorder and other psychiatric disorders

L. Guidelli, A. Goracci, M. Martinucci, S. Rossi, A. Di Muro, P. Castrogiovanni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

401

P.3.026 Tiagabine as an efficacious augmentation therapy to selective serotonin reuptake inhibitors in patients with generalized anxiety disorder

A. Khans, T.L. Schwartz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

402

P.3.027 Fluoxetine in the treatment of combat relatedPTSD: A subanalysis of a placebo-controlled trial of Bosnian, Croatian and Serbian veterans of the war in the former Yugoslavia (1992–1995)

F. Martenyi, B.B. Basson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

403

P.3.028 Cardiac autonomic activity in panic disorder patients

N. Atasoy, M. Aydin, R. Davutoglu, N. Konuk, O. Simsekyilmaz, L. Atik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

404

P.3.029 Anxiolytic effect induced by nitric oxidesynthase inhibitors microinjected at medial amygdala of rats

R.M.W. Oliveira, D. Forestiero, C.M. Manfrim, F.S. Guimaraes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

405

P.3.030 Monotherapy with benzodiazepines or SSRIsversus combined treatment in a sample of primary care patients with panic disorder

K.M. Maki, R.B. Weisberg, I. Dyck, M.B. Keller

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

406

P.3.031 Association study of 90 candidategenetic polymorphisms in panic disorder: Positive findings with SNPs in serotonin, cholecystokinin and dopamine related genes

E. Maron, T. Nkopensius, S. Kõks, S. Altmäe, E. Heinaste, K. Vabrit, V. Tammekivi, P. Hallast, K. Koido, A. Kurg, A. Metspalu, E. Vasar, V. Vasar, J. Shlik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

407

P.3.032 White matter changes in obsessive-compulsive disorder

T.J. Raedler, M.A. Koch, M. Rufer, I. Hand, C. Buechel

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

408

P.3.033 Acute and chronic stress alter cannabinoid CB1 receptor function and POMC gene expression in the rat brain

S. Pérez-Rial, L. Urigüen, T. Palomo, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

409

P.3.034 Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety

D. Consoli, T. Incognito, C. Mazzola, V. Micale, F. Drago

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

410

P.3.035 NK 2 receptor: A new target for depression therapy

V. Micale, C. Mazzola, D. Consoli, F. Drago

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

411

P.3.036 Pregabalin in the treatment of core depressive symptoms in generalized anxiety disorder

A. Khan, S.A. Montgomery, N. Simon, G. Farfel, K. Tobias, G.L. Zornbetg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

412

P.3.037 A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia

A.A. Patkar, P.S. Masand, W. Jiang, S. Krulewicz, E. Dube, C. Purcell, C. McMorran, K. Peindl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

413

P.3.038 Efficacy of pregabalin in clinically relevantsubtypes of generalized anxiety disorder

M.H. Pollack, S. Kasper, C.K. Cohn, G. Farfel, G.L. Zornberg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

414

P.3.039 Anxiolytic-like behavior after depletion of theserotonergic and noradrenergic systems in the rat

G. Levay, N. Sziray, B. Mark, G. Kapus, I. Gacsalyi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

415

P.3.040 Contribution of high-affinity binding at calcium channel α2-δ proteins to the pharmacology of pregabalin

S. Donevan, C.P. Taylor, J. Offord, T.Z. Su, S. Baron, J. Kinsora, M.G. Vartanian, F. Bian, Z. Li, D. Dooley, D.j. Wustrow, T. Belliotti, J. Schwarz, A. Thorpe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

416

P.3.041 Increased anxiety-like behaviours in micedeficient in prodynorphin gene

L. Urigüen, S. Pérez-Rial, A. Stefanescu, T. Palomo, J. Marrvanares

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

417

P 3.042 Platelet alpha2-adrenoreceptors in obsessive-compulsivedisorder

D. Marazzi, B. Dell'Osso, S. Baroni, I. Mesala, L. Vivarelli, E. Di Nasso, F. Mungai, G. Giannaccini, D. Marazzi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

418

P3.043 Subjective and neurovegetative changesin healthy volunteers and panic patients performing simulated public speaking

C.M. Del-Ben, F.G. Graeff, A.C.V Parente, C. Garcia-Lea, F.S. Guimaraes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

419

P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography

J.R. Nash, P.A. Sargen, E.A. Rabiner, S.D. Hood, S.V. Argyropoulos, R.M. Grasby, D.I. Nutt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 225 KB

english, 2004

420

P4.001 The neuroprotective effects of gossypin

L.K.H. KwangHeun Lee, I.J.Y. Injae Yoon, C.J.S. Changjin Song, J.S.C. Jungsook Cho

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

421

P4.002 Down-regulation of dopamine D1 andD2 receptors in the basal ganglia of the pentylenetetrazol kindling model of epilepsy: Effects of angiotensin IV

J.D. Tchekalarova, V. Sotirou, F. Angelatou

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

422

P4.003 Isopeptide cross-links in neurofibrillary tangles and levy bodies are confined to the same sequence positions of ubiquitin, HSP27, parkin and αsynuclein

Z. Nemes, L. Deli, M.A. Demeny, B. Devreese, G. Petrovoski, J. Vanbeeumen, L. Fesus

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

423

P4.004 General anaesthesia and chronic postoperative cognitive dysfunction

H. Wellner, S. Jungwirth, P. Fischer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

424

P4.005 Long-term memantine treatment preventsbehaviour deficits in a mouse model of sporadic Alzheimer's disease

I. Egebjerg, A. Westlind-Danielsson, S. Capsoni, A. Cattaneo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

425

P4.006 Neuroprotective properties of memantine indifferent models of excitoxicity

M. Leist, C. Volbracht, J. van Heek

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

426

P4.007 Learning-enhancing and anxiolytic effects of memantine in nontransgenic and transgenicmice over-expressing APPswe and PS1

T. Heikki, R. Minkeviciene, P. Banerjee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

427

P4.006 P300 as a measure for reflecting cognitivedysfunctions in patients with brain concussion

S.I. Han, Y.W. Jeon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

428

P4.009 Motor and cognitive features during protractedcortico-subcortical neurodegeneration following transient, focal cerebral ischemia in the rat

T.J.P. Moreira, G. Cebere, S. Liljequiet, A. Wägner

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

429

P4.010 Parietal brain oxygenation is altered inAlzheimer's disease as assessed with Near-Infrared Spectroscopy (NIRS)

A.I. Fallgatter, A.C. Ehlie, M.I. Herrmann

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 108 KB

english, 2004

430

P4.011 Functional benefit of memantine treatment inpatients with moderate to severe Alzheimer's disease

Y. Wirth, R.S. Doody, F.A. Schmitt, H.J. Moebius, A. Stoeffler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

431

P4.012 Memantine treatment for mild to severeAlzheimer's disease: Clinical trials summary

P.N. Tariot, R.S. Doody, E.R. Peskind, H. Winblad, A. Stoeffler, H.J. Moebius, S.M. Grahams, S. McDonalds

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

432

P4.013 Effects of donepezil on behavioral andpsychological symptoms in Korean patients with Alzheimer's disease

J.S. Yoon, J.M. Kim, I.S. Shin, S.W. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

433

P4.014 Galantamine improves attention in patientswith mild to moderate Alzheimer's disease

S. Sohwalen, B. Vellas, B. van Baelen, G. Hammond

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

434

P4.016 Comparison of mild cognitive impairment and Alzheimer dementia in implicit memory performance: A controlled study

A. Akdemir, S. Orsel, B. Cangöz, K. Selekler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

435

P4.017 Proton magnetic resonance spectroscopy(1HMRS) in the evaluation of brain metabolites changes in dementia with Lewy bodies and Alzheimer's disease

R. Magiereld, A. Rotkiewicz, W.G. Grajewicz, I. Karlinska, B. Goraj, I. Kloszeweska, T.M. Sobow

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 225 KB

english, 2004

436

P4.018 Comparative neuropsychological assessment in dementia with Lewy bodies and Alzheimer's disease

R. Megierski, I. Karlinska, I. Kloezeweka, T.M. Sobow

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

437

P4.019 Differential diagnosis of leukodystrophies with magnetic resonance spectroscopy in vivo

S.S.I. Saukovio, D.V. Diklic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

438

P4.020 Psychiatric morbidity, quality of life anddisability in mesial temporal lobe epilepsy patients before and after epilepsy surgery

E.S. Cankurtaran, B. Ulug, S. Saygý

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

439

P4.021 Robust response to memantine treatmentwhen functional and behavioral results are combined with cognition

F.A. Schmitt, P.N. Tariot, J.L. Cummings, J.M. Bell, D. Jia, J.T. Olin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

440

P4.022 Memantine monotherapy is effective andsafe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial

E.R. Peskind, S.G. Potkin, N. Pomara, B.R. Ott, S. McDonald, Y. Xie, I. Gergel

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

441

P4.023 Memantine monotherapt increase brainmetabolism (PET) and effectively treats mild to moderate Alzheimer's disease

S.G. Potkin, S. McDonald, I. Gergel, G. Alva, D.B. Keator, J.H. Fallon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

442

P4.024 Proroten, ultra-low doses of antibodies toS-100 protein, reduced brain damage in photochemically-induced photothrombosis

G.A. Romanova, S.A. Sergeeva, T.A. Voronina, O.I. Epstein, J.L. Dugina, I.V Barskov

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

443

P4.025 Study of ancholinesterase drugs galanthamine anddonepezil on scopolamine-induced amnesia in rats

A. Spassov, D.P. Getova, D.S. Dimitrova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

444

P4.026 Galantamine prolonged-release formulation permits once-daily dosing in patients with mild to moderate Alzheimer's disease

H. Brodaty, S. Schwalen, M. Gold

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

445

P4.027 Galantamine in advanced moderate Alzheimer'sdisease: Long-term benefits and the effect of delayed initiation of treatment

R. Bles, B. van Baelen, S. Kavanagh

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

446

P4.028 Functional and behavioral effects of memantinein Alzheimer's disease

C.H. van Dyck, J. Cummings, F. Schmitt, S.M. Graham, J.T. Olin, J. Jin, P.N. Tariot

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

447

P4.029 A comparison of wildtype and APP transgenic mice on titrating delayed non-match to position (DNMTP) and differential reinforcement of low rates (DRL) performance

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

448

P4.030 Risperidone is not associated with higher riskof stroke in dementia patients compared to other psychotropics: Results from Medicaid data 1999–2001

C.M. Kozma, L.M. Engelhart, S. Long, A. Greenspan, R. Mahmoud, O. Baser

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

449

P4.031 Effects of cerebrum compositum and ubichinoncompositum in patients with postradiation on brain damage

L.A. Zhavoronkova, N.B. Kholodova, G.A. Zubovsky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 217 KB

english, 2004

450

P4.032 The effects of scopolamine in elderly volunteers using the Cogtest battery

R. Bilder, T. Sharma, D. Wilkinson, R. Jones, J. Harrison

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

451

P4.033 The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain

C. Mazzola, V. Micale, D. Coneoli, T. Incognito, G.M. Leggio, V. Di Marzo, F. Drago

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 222 KB

english, 2004

452

P4.034 The influence ofsocio-demographic factors oncognitive functions in in population over 65 years

L. Bidzan, J. Turczynski

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

453

P4.035 Is Pseudologia Fantastica (PF) a neurological disease associated with schizophrenia

A. Jensen, D. Nonrum, O.Ø. Ruud, M. Lindgren, L. Stubberud, L. Pederstad

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

454

P4.036 Campylobacter-associated Guillain Barré syndrome atAlexandria University Hospital

M.E. Saygh, M.F. Boraey

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

455

P4.037 Study of anticholinesterase drug metrifonateon learning and memory in rats with impaired memory

D.P. Getova, D.S. Dimitrova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

456

P4.038 Prevention of brain ATP depletion after acute stress accounts for 15d-PGJ2 and rosiglitazone anti-excitotoxic effect

H. García-Sueno, J.R. Caso, M.P. Pereira, J. Pradillo, I. Lizasoain, M.A. Moro, P. Lorenzo, J.C. Leza

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

457

P5.000 Alcohol-seeking and self-administration:Effects of a sono tonin 1B agonist in the nucleus accumbens

C.L. Czachoweld

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

458

P5.001 A prospective study on the genetic andPsychosocial effects on the change of alcohol drinking behavior of freshmen of a university

S.I. Lee, H. Kim, I.W. Chung, C.J. Shin, S.M. Hong, Y.M. Kwon, K.H. Chi, K.Y. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

459

P5.002 Erectile dysfunction among inpatient alcoholdependents and it's relationship with depression, anxiety, and alexithymia

C. Evren, S. Can, C. Duran

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

460

P5.003 Temperament and character inventory insubstance dependents: A controlled study

C. Evren, Y. Can, C. Yancar, O. Saatcioglu, D. Cakmak

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 217 KB

english, 2004

461

P5.004 Suicide attempt history in substancedependents and its relationship with sociodemographic and clinical characteristics

C. Evren, S. Kural, D. Cakmak

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 106 KB

english, 2004

462

P5.005 Influence of adenosine A2A receptor agonist (CGS 21680) and antagonist (MSX-3) on the locomotor and sensitizing effects of cocaine

M. Filip, M. Frankowska, E. Przegaliński, C.E. Müller, K. Fuxe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 106 KB

english, 2004

463

P5.000 Haloperidol reduces excessive attention onheroin cues in abstinent heroin dependent patients

I.H.A. Franken, V.M. Hendriks, C.J. Stam, W. van den Brink

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

464

P5.007 Association of insight level with negativealcoholism screening tests in alcohol-dependent patients

S.G. Kim, S.K. Sung, Y.K. Min, S.Y. Kim, M.J. Kim, C.J. Kang

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

465

P5.008 Neural mechanisms of working memory in ecstasyusers who continue or discontinue ecstasy use: A longitudinal fMRI study

J. Daumann, T. Fischermann, A. Thron, E. Gouzoulie-Mayfrank

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 219 KB

english, 2004

466

P5.009 Defense mechanism and insight in relation toexecutive function of alcoholic patients

K.S. Lee, K.C. Kim, K.H. Sung, S.E. Shin, K. Jung

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

467

P5.010 Frontal lobe function in alcohol dependence:Selective impairment of verbal working memory correlates to alcohol consumption

D.I. Jon, S. Hwang, H. Lee, E.H. Ha, B. Lee, N. Kee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 219 KB

english, 2004

468

P.5.011 The selective NR2B antagonist Ro 25-6981 potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens

A.R. Kosowski, S. Liljequist

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

469

P5.012 Cue-induced behavioural activation: Strain, schedule and stress differences in alcohol response

C. Pickering, S. Liljequist

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

470

P5.013 The selective delta opioid agonist SNC 80 potentiates cocaine-induced locomotor activity without concomitant increase in dopamine release in the nucleus accumbens

A.C. Swanhagen, A.R. Kosowski, M.D.B. Swedberg, S. Liljequist

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

471

P5.014 Decreased platelet vesicular monoaminetransporter density in habitual smokers

K. Schwartz, A. Weizman, M. Rehavi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

472

P.5.015 The influence of felbamate on sensitization to methamphetamine behavioural effects in mice

L. Landa, K. Slais, A. Sulcova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

473

P.5.616 Comparison of characteristics betweenalcoholism only and dually diagnosed alcoholism

S.W. Moon, B.W. Nam, J.S. Seo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

474

P.5.617 Olanzapine vs chlorpromazine in thedetoxification of heroin dependents

H.R.C. Rashid, I.A. Ahmad, M.M.I. Iqbal, K.A.M. Mufti

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

475

P.5.018 Relationships between lifetime alcohol consumption and cognitive function in a Korean elderly population

J.M. Kim, S.H. Kim, S.H. Park, H.R. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

476

P.5.019 Cues impact on craving and mood, duringbelay periods of free smoking and abstinence

V. Teneggi, L. Squassante, L. Ziviani, S. Milleri, A. Bye

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

477

P.5.020 Effect of Radix puerariae on alcohol craving and regional cerebral blood flow in the patients with alcohol dependence

M.J. Kim, S.G. Kim, J.M. Park, C.J. Kang

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

478

P.5.021 Buprenorphine treatment: M update

P. Vigezzi, L. Guglielmino, R. Silenzio, M. De Chiara, F. Corrado, P. Marzorati, L. Cocchi, E. Cozzolino

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

479

P.5.022 Nicotine-induced antinociception, rewardingeffects and physical dependence are mediated by pre-proenkephalin derivates

F. Berrendero, V. Mendizábal, P. Robledo, L. Galeote, A. Bilkei-Gorzo, A. Zimmer, R. Maldonado

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 232 KB

english, 2004

480

P.5.023 Substance use disorder in psychiatric inpatient

S.W. Moon, W. Hahm, B.W. Nam, J.S. Seo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

481

P.5.024 Levetiracetam for the treatment of alcohol withdrawal: An open prospective clinical trial

K. Leopold, M. Krebs, T. Kienast, T. Noack, C. Richter, A. Gabriel, R. Jeutner, A. Heinz, M. Schaefer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

482

P.5.025 C-terminal fragment of cocaine- andamphetamine-regulated transcript peptide attenuates cocaine- and amphetamine-induced hyperlocomotion in mice

T. Dylag, J. Kotlinska, P. Rafalski, J. Silberring

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

483

P.5.026 Evaluation of dysphoric properties of nicotine withdrawal in mice

E. Aso, O. Valverde, R. Maldonado

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

484

P.5.028 Sensitization of amphetamine-induced stereotyped behaviour during the acute response and possible role of environmental conditioning in mice

C.C. Chinen, R.R. Faria, R. Frussa Filho

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

485

P.5.029 Evidence of elevated homocysteine levels inalcoholism

S. Bleich, D. Bönsch, J. Kornhuber

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

486

P.5.080 Gamma-hydroxybutyric acid inhibits ethanol-induced narcosis

M. Castorina, T. Incognito, F. Drago

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

487

P.5.031 Association of gene polymorphism and temperament with cigarette smoking in Korean adolescents

I.H. Cho, Y.W. Bang, Y.S. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

488

P.5.032 Chronic moderate ethanol consumption increases cell proliferation and neurogenesis in the adult mice hippocampus

E.A. Áberg, C. Hofstetter, L. Olson, S. Brené

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

489

P.5.033 Elevated alpha patients levels are associatedwith craving in patients with alcoholism

D. Bönsch, U. Reulbach, K. Bayerlein, T. Hillemacher, J. Kornhuber, S. Bleich

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

490

P.5.034 Czech university students and drugs of abuse:Preliminary results of urinalysis

A. Kavalirova, V. Vorisek, J. Ulvrova, P. Visnovsky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

491

P.5.035 and motivational manifestations of nicotinewithdrawal in mice

G.N. Balerio, E. Aso, E. Berrendero, R. Murtra, R. Maldonado

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

492

P.5.036 Effect of citral intraventricular administration on the brain ALDH activity and acetaldehyde levels during acute alcohol intoxication in rats

S.P. Pronko, A.L. Buben, A.V. Naumov, S.M. Zimatkin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

493

P.5.039 Acamprosate counteracts anxiety-like behaviorinduced by multiple ethanol withdrawals

D.H. Overstreet, D.J. Knapp, G.R. Breese

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

494

P.5.039 Adaptation and validation of the ASAM PPC-2R

J. Reggers, M. Ansseau, F. Gustin, S. Pirard, P. van Deun, A. Seghers, P. Earley, J. Besson, D. Gastfriend

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

495

P.5.040 Amisulpde may help with alcoholdetoxification: A pilot study

J. Liappas, T. Paparrigopoulos, E. Tzavellas, A. Rabavilas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

496

P.5.041 Rewarding stimulus associated with cocaine self-administration prevents the depression of catecholamine metabolism in rat brain following cocaine withdrawal

L. Antkiewicz-Michaluk, I. Romańska, M. Filip, A. Patsenka, J. Michaluk

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

497

P.5.042 Gene transcription alterations associated to naltrexone treatment induces a decrease in alcohol intake in alcohol-preferring Wistar rats

J.M. Oliva, T. Palomo, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 122 KB

english, 2004

498

P.5.043 Risk factors of personality dimensions of theTCI in the initiation of smoking in adolescents

S.K. Lee, H.S. Lee, D.W. Chang, H.J. Go, B.K. Son

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

499

P.6.001 Dl-receptors involve in behavioral and hormonal responses in intact and ovariectomized female rats

J. Fedotova, N. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

500

P.6.002 The monitoring of QTc interval in patients treated with psychotropic drugs

E. Ceskova, T. Novotný, A. Florianova, R. Prikryl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

501

P.6.003 Nicotinic receptor-induced hypothermia:A pharmacological evaluation

A. Kleefstra, J. Glennon, A.C. McCreary

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

502

P.6.004 Gene expression profiling of SH-SY5Y human neuroblastoma cells following treatme nt with ginsenoside Rbi or Rgi

J.N. Lee, B.H. Yang, Y.G. Chai, K.H. Jung, J.S. Lee, K.J. Choi, Y.S. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

503

P.6.005 Effect of caffeine on daytime sleepiness and cognitive dysfunction induced by sleep deprivation

S.K. Wang, H.S. Choi, Y.O. Shin, I.S. Chee, S.W. Lee, J.L. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

504

P.6.006 Electroconvulsive therapy: Assessment of practice of 12 year period in a university hospital

C. Zeren, L. Tamam, Y.E. Evlice

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

505

P.6.007 Alpha2-Macroglobulin axon 24 (Val-1000-Ile)polymorphism in Lewy body disease

A. Juhász, Á. Rimanóczy, J. Kálmán, É. Csibri, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

506

P.6.008 Treatment of pain, depressive and anxietysymptoms in fibromyalgia with venlafaxine

H. Evren, C. Evren, M. Hosafei Guler

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

507

P.6.009 Bright light treatment in anorexia nervosa

M. Janas-Kozik, I. Krupka-Matszczyk, M. Krystanek, H.I. Trzeciak, J. Szymszal

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

508

P.6.010 Distribution of 5-HT6 and 5-HT7 receptors in the human brain

K. Varnäs, D.R. Thomas, W.D. Hirst, H. Hall

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

509

P.6.011 Modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

510

P.6.012 Effects of environmental conditioning on SKF 38393-induced grooming behavior and quinpirole-induced stereotyped behavior after long term dopaminergic antagonists treatment

C.C. Chinen, J.A.O. Tatsu, R. Frussa Filho

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

511

P.6.013 EEG-effects of gustatory and olfactory stimuli in anorexia nervosa

E. Toth, F. Túry, A. Gáti, J. Weisz, I. Kondakor, M. Molnár

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

512

P.6.014 Psychomotor and cognitive effects of lorazepam and d-amphetamine in healthy subjects: Development of sensitive screening tests of psychomotor- and cognitive functions

E. Wezenberg, W. Hulstijn, B.G.C. Sabbe, G.S.F. Ruigt, R.J. Verkes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

513

P.6.015 Age-related changes in erythropoietinimmunoreactivity in the cerebral cortex and hippocampus of rats

S.I. Kim, H.W. Woo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

514

P.6.016 Association between serotonin 2A and 1Breceptor gene polymorphism and suicidal attempt using drug intoxication in Koreans

Y.J. Kwon, D.H. Kim, Y.S. Na, S.H. Han

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

515

P.6.017 Study of dependence effects of semax analogues in dependence on their structure

N.Y. Glazova, N.G. Levitskaya, L.A. Andreeva, N.F. Myasoedov, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

516

P.6.018 Modafinil as therapy for ADHD in children: A 4-week, double-blind, placebo-controlled study

J. Biederman, J.M. Swanson, S.W. Boellner, F.A. Lopez

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

517

P.6.019 Quetiapine augmentation of serotonin reuptakeinhibitors ina refractory-obsessive compulsive disorder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

518

P.6.020 Suicidal behavior and psychopathology in adolescents — results of a self-report survey among 15 and 16-year old adolescent people in Hungary

S. Fekete, V. Voros, P. Osvath

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

519

P.6.021 Neural mechanism of moral judgment using facial affect in an emotional context: 3T fMRI study

J. Kim, B.S. Jeong, S.W. Kee, S.H. Lee

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

520

P.6.022 Reduction by SSR125543A, a CRF1 receptor antagonist, of schedule-induced polydipsia suggests an anti-stress action in this procedure

A. Pério, R. Depoortèe, G. Griebel, P. Soubrié

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

521

P.6.023 Experience of rearing circumstances in relation to course of illness in patients with therapy-refractory affective disorders

A. Ehnvall, A. Palm-Beskow, J. Beskow, H. Ågren

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 220 KB

english, 2004

522

P.6.024 Quality-of-life assessment in atomoxetine-treatedadult patients with attention-deficit/hyperactivity disorder

L. Adler, D.K. Kelsey, A. Dietrich, F. Reimherr, R.B. Sandal, K. Saylor, K. Secnik, V. Sutton, R. Moore

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

523

P.6.025 Tianeptine inhibits pentylenetetrazole-induced seizures in mice via adenosinergic receptors

L.T. Uzbay, H. Kayir, M. Ceyhan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

524

P.6.026 No association between the tryptophanhydroxylase gene polymorphism and major depressive disorders and antidepressant response

M.S. Lee, B.J. Ham, R.H. Kang, M.J. Chor, Y.M. Kwon, S.H. Kan, S.J. Lee, Y. Song

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

525

P.6.027 Intravenous infusion of allopregnanolone induces sedation in humans

F. van Broekhoven, T. Bäckström, J. Sundström, E.L. van Luijtelaar, R. Smits, R.J. Verkes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

526

P.6.028 Transnosography of impulsiveness:A comparison among different psychiatric disorders

M. Martinucci, A. Goracci, A. Mazza, G. Fllippone, P. Castrogiovanni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

527

P.6.030 Analysis of the role of brain 5-HT1A receptors in spatial and aversive learning in the rat

M. Lüttgen, E. Elvander, N. Madjid, O.S. Ögren

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 231 KB

english, 2004

528

P.6.031 Aggressiveness and impulsiveness: Twodimensions with a mutual relationship

A. Goracci, M. Martinucci, A. Mazza, G. Filippone, P. Castrogiovanni

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

529

P.6.032 10 Year follow-up study of males with ADHD

J. Biederman, E. Mick, S.V. Faraone

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

530

P.6.033 5 Year follow-up study of females with ADHD

E. Mick, J. Biederman, S.V. Fareone

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 222 KB

english, 2004

531

P.6.034 Role of dopamine D1 receptor on dopaminergic supersensitivity induced by sleep deprivation in mice

C.C. Chinen, R.R. Faria, R. Frussa Filho

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

532

P.6035 Baseline information on symptom severity, diagnosis, and treatment prescribed: Results from adore

S.I. Ralston, M.J.M. Maria Lorenzo

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 110 KB

english, 2004

533

P.6.036 Stress in hyperhomocysteinaemic rats induced platelet activation

K.A. Cherkasova, O.S. Nurutdinova, A.A. Kubatiev

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

534

P.6.012 Effects of environmental conditioning on SKF 38393-induced grooming behavior and quinpirole-induced stereotyped behavior after long term dopaminergic antagonists treatment

J.K. Buitelaar, D. Michelson, M. Danckaerts, C. Gillberg, T. Spencer, A. Zuddas, D. Faries, S. Zhang, J. Biederman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

535

P.6.038 Supporting tools in psychopharmacology: Theartificial neural network method in psychiatric treatment decision making

L. Franchini, E. Politi, C. Chiara, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004

536

P.6.039 Atomoxetine treatment in children with attention-deficit/hyperactivity disorder and comorbid tic disorders

A.J. Allen, R.M. Kurlan, S.L. Linder, D.W. Lewis, P.K. Winner, D.L. Gilbert, D.W. Dunn, F.R. Sallee, D.R. Milton, M.I. Mintz, R.K. Ricardi, G. Erenberg, L.L. Layton, P.D. Feldman, D.K. Kelsey, T.J. Sp

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

537

P.6.040 Time of hospitalization in mania using atypicalversus conventional antipsychotics

M.C. Garcia Mahia, R. Castro Calvo, C. Pedrejon Molino, M. Vidal Millares, C. Gonzalez Borras

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

538

P.6.041 Pain response patterns and expression of estrogen-α receptors in androgenized female mice

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

539

Cognitive functioning in Lyme borrellosis

D. Juchnowicz, B. Konarzewska, R. Popawska

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

540

P.6.043 Comorbidity of personality disorders

M. Vidal Millares, M.C. Garcia Mahia, J. Brenlla Gonzalez, C. Cimadedla Alvarez, C. Pedreion Molino, P. Varela Casal

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

541

P.6.044 Anxiety sensitivity and dimensions ofalexithymia in depressive, anxiety and somatoform disorders

F. Celikel, O. Saatcioglu

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

542

P.6.045 Patterns of motor activity in schizophrenia anddepression

E.R. Hauge, J.Ø. Berle, S. Thoppil, K. Oedegaard, F. Holsten, O.B. Fasmer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

543

P6.046 Pattern of benzodiazepines utilization in the population of elderly treated in their homes

L. Jovanic, M. Prostran

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

544

P6.047 A pharmacokinetic interacfion study oflamotrigine and olanzapine

G.E. Evoniuk, J. Ascher, J. Sidhu, S. Job, J. Theis

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

545

P6.048 Patient functional status/quality of life, safety,and tolerability with long-term modafinil in chronic shiftwork sleep disorder

T. Roth, C.A. Czeisler, M.K. Erman, J.K. Walsh, J.R.L. Schwartz, R. Rosenbergs, B.C. Corser, D.F. Dinges

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

546

P.6.049 The impact of schizophrenia on caregivers; a pilot study

S. Crowley, J. Adams, C. LeReun, V. Nandand, A. Egglesten, R. Schrover

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

547

P.6.050 Anxiety depression and quality of life inpatients with solid cancer during the palliative chemotherapy

I.H. Cho, Y.W. Bang, S.M. Bangt, S.H. Park

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

548

P.6.051 Association between seasonal mood variationand G-protein beta 3 nt polymorphism in a healthy young population

H.J. Lee, L. Kim

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

549

P.6.052 The effect of lamotrigine on depressiveand convulsive modifications induced by pentetrazole and reserpine in mice

M.A. Birt, V. Sandor

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 115 KB

english, 2004

550

P.6.053 Prevalence of depression in diabetic adultswith metabolic syndrome

K.P. Kouniakis, B.M. Baltatzi, T.E. Tsirogianni, K.S. Karabatsou, S.C. Savopoulos, H.A. Hatzitolios, A.M. Alevizos

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

551

P.6.054 The antinociceptive effect of oxcarbazepine in a rat model of inflammatory hyperalgesia

M. Tomic, S. Vuckovic, R. Stepanovic-Petrovic, N. Ugresic, M. Prostran, B. Boskovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

552

P.6.055 Higher ambient temperature, thermoregulatory behaviour, and the cataleptic effect of fentanyl in rats

Z. Nesic, S. Vuckovic, M. Prostran, Z. Todorovic, R. Stojanovic, M. Ivanovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

553

P.6.056 Caffeine antagonizes the antinociceptive effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia

R. Stepanovic-Petrovic, M. Tomic, S. Vuckovic Ugresic, M. Prostran, B. Boskovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

554

P.6.057 Serum BDNF levels in conversion disorder:A comparative study with depression

A. Deveci, O. Aydemir, E.O. Taskin, F. Taneli, A. Esen-Danaci

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

555

P.6.058 Modafinil reverses the marked attentionaldeficits produced by acute sleep deprivation in healthv volunteers

K.A. Wesnes, J.P. Macher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

556

P.6.059 The involvement of adenosine A1 receptors in the antinociceptive effects of carbamzaepine and oxcarbazepine in a rat model of inflammatory hyperalgesia

M. Prostran, M. Tomic, S. Vuckovic, R. Stepanovic-Petrovic, N. Ugresic, B. Boskovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

557

P.6.060 The memory enhancing effects of ginkgo biloba in healthy middle-aged volunteers

K.A. Wesnes, J. Ferguson, O. Petrini

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 94 KB

english, 2004

558

P.6.061 In vitro effect of melatonin on the hippocampalsomatostatin receptors

M.C. Boyano-Adánez, R.M. Izquierdo-Claros, A. Martín-Garrido, M. Rodríguez-Puyol, D. Rodriguez-Puyol, L. Puebla, E. Arila-Ferreiro

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 186 KB

english, 2004

559

P.6.062 Antagonism of the mGlu5 receptor induces a delay-dependent impairment in delayed-matching-to-position at a dose that does not affect attentional performance or prepulse inhibition

S.L. Dix, J.W. Smith, Y. Thomas, R.S. Mann, M.D. Tricklebank

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 97 KB

english, 2004

560

P.6.063 Taste perception alteration in anorexia nervosapatients

Á. Gib, B. Lukáts, C. Szalay, S. Papp, Z. Karádi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 211 KB

english, 2004

561

P.6.064 Platelet serotonin, monoamine oxidase activity and serum lipids in psychotic and nonpsychotic subtypes of mania

D. Mueck-Seler, N. Pivac, M. Sagud, M. Mustapic, A. Mihaljevic-Peles

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

562

P.6.065 Anti-stigma projects against the discrimination of psychiatric patients. A literature search and a world-wide survey

K. Wundmm, G. Pitschel-Walz, C. Rummel, W. Kissling

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

563

P.6.066 Pharmacological and genetic analysis of thenociceptin system and learning/memory in mice

A. Kuzmin Madjid, L. Terenius, S.O. Ögren

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

564

P6.667 Escitalopram, paroxetine and sertraline, do they differ in their ability to inhibit serotonin transport? What can we learn from pre-clinical models?

L.T. Brennum, C. Sánchez, A.K. Larsen, T.I.F. Cremers, M. Kreilgaard, C. Thomsen

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 120 KB

english, 2004

565

P.6.066 Characterization of two overlappingS-citalopram binding sites on the serotonin transporter

F. Chen, M.B. Larsen, H.A. Neubauer, S. Sinning, P. Plenge, C. Sánchez, O. Wiborg

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

566

P.6.069 Standardisation and cross validation study ofCogtest — an automated neurocognitive battery for use in clinical trials

T. Sharma, R. Bilder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

567

P.6.070 A pharmacological basis for asub-classification of SSRIS. R-citalopram interacts differently with SSRls in vivo

T.I.F. Cremere, B.H.C. Westerink, C. Sánchez

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

568

P.6671 In vivo electrophysiological study of the effects of escitalopram on the rat serotonergic neurotransmission

M. El Mansari, C. Sánchez, G. Chouvet, N. Haddjeri

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 114 KB

english, 2004

569

P.6.672 Neuromodulators in central regulation of heart rate dynamics: Implications for autonomic dysregulation associated with psychiatric disorders

O. Stiedl, S.O. Ögren, M. Meyer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

570

P.6.073 Subjective and physiological acute effects oforally administered cannabis extract in healthy females

R.M. Kaufmann, B. Kraft, R. Frey, C. Bker, S. Kasper, H.G. Krens

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

571

P.6.074 A psychophysiological investigation into violence and mental illness

V. Kumari, M. Das, E. Zachariah, I. Barkataki, P. Taylor, T. Sharma

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 118 KB

english, 2004

572

P.6.075 Basic nutritional advice for overweight people with serious mental illness

R.I. Ohlsen, G. Peacock, S. Smith

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

573

P.6.076 Psychological factors and H. Pylori infectionon non-ulcer dyspepsia patients

S.Y. Wang, C.P. Shu, D.Q. Wu, W.M. Wang, Y.C. Su, C.H. Lin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

574

P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome

A.J. Cleare, A. Roberts, A. Papadopoulos, T. Chalder, S. Wessely

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

575

P.6.078 Response to methylphenidate in adult ADHDpatients depends on striatal dopamine transporter density

K.H. Krause, J. Krause, S.H. Dresel, C. LaFougere, M. Ackenheil

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

576

P.6.079 Depression and anxiety inpatients with congestive heart failure — preliminary report

D. Lojko, R. Dankowski, A. Suwalska, A. Rajewski, M. Wierzchowiecki

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

577

P.6.080 Nitric oxide and dopamine interaction on prepulse inhibition of the acoustic startle response of rate

C. Salum, F.S. Guimaraes, M.L. Brandao, E.A. Del Bel

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

578

P.6.081 Lack of adjustment for nutrition and undiagnosed Diabetes Mellitus (DM) type 2 in retrospective studies evaluating the link between DM type 2 and atypical antipsychotics

K. Cerri, S. Gough, C. Bushe

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

579

P.6.082 Nicotine-induced net and state-dependent decreases of pupillary fluctuations in healthy young non-smokers

Z. Tokaji, J. Kálmán, A. Szabo-Nagy, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 225 KB

english, 2004

580

P.6.083 Characterization of the dopamine transporter in human blood platelets

D. Marazziti, S. Baroni, L. Betti, L. Febbrini, P. Italiani, F. Mungai, B. Dell'Osso, G. Giannaccini

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

581

P.6.084 Association study of dopamine transportergenotypes and correlation with striatal [123I]-β-CIT binding in Tourette's disorder

M. Stamenkovic, J. Stastny, F. Riederer, F. Leisch, K. Fuchs, S. Asenbaum, A. Konstantinidis, Ch. Gebhart, S.D. Schindler, P Schüssler, K. Hornik, W. Sieghart, G. Pakesch, S. Kasper, H.N. Asthauer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

582

P.6.085 Modified behavioral test for estimation of malemice sexual motivation

A.V. Amikishieva

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

583

P.6.086 Dependence of semax long-lasting effects onthe time of its neonatal administration

E.A. Sebentsova, N.G. Levitskaya, L.A. Andreeva, L.Y. Alfeeva, N.F. Myasoedov, A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

584

P.6.087 Attempted suicide, psychopathology and genetic background — results of a family based association study in Hungary

S. Fekete, P. Osvath, P. Zill, B. Bondy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

585

P.6.088 The influence of food-derived mother-dependent peptide beta-casomorphin-7 on mother-dependent albino rat pups behaviour

V.A. Dubynin, J.A. Slusarenko, J.V. Dobryakova, I.S. Stovolosov, L.A. Andreeva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

586

P.6.089 The safety of new mood stazers inpregnancy and lactation

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 223 KB

english, 2004

587

P.6.090 Study of mechanisms of the ACTH(4-10)analogue SEMAX analgesic activity

D.M. Ivanova, D.A. Vilensky, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

588

P.6.091 The behavioral and biochemical consequencesof acute perinatal hypoxia in descendants depend upon the period of pregnancy

A.V. Graf, M.V. Maslova, A.S. Maklakova, N.A. Sokolova, N.U. Kudryashova, Ja.V. Krushinskaya, E.N. Goncharenko, A.A. Bayzhymanov

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 137 KB

english, 2004

589

C.0301 SSRIs and SNRIs: Perceptions, facts, andclinical outcomes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 106 KB

english, 2004

590

C.03.02 Critical appraisal of comparative depression and anxiety treatment data

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

591

C.03.03 Psychiatric and medical comorbidity: Treatment considerations in special patient populations

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 237 KB

english, 2004

592

C.03.04 Treatment of recurrence in depression: Long-term prevention of a chronic illness

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 230 KB

english, 2004

593

C.04.01 The mood spectrum: Improving the diagnosis of bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

594

C.04.02 Translating knowledge of genetics andpharmacology into improving everyday practice

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 241 KB

english, 2004

595

C.04.03 Newer pharmacological options for mania andmaintenance therapy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 239 KB

english, 2004

596

C.04.04 Bipolar depression: A new role for atypicalantipsychotics

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

597

C.05.01 It's about recognition

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

598

C.05.02 It's about tim — 1 week makes a difference

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

599

C.O5.03 It's about selectivity — dual or single action

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 122 KB

english, 2004

600

C.05.04 It's about mode of action — SSRIs are different

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 234 KB

english, 2004

601

C.07.01 Dopamine partial agonists as an approach for treating schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

602

C.14.01 Discerning differences in antidepressants: Clinical trial design, mets-analysis and outcomes interpretation

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 238 KB

english, 2004

603

C.14.02 Optimizing outcomes in depression: The critical role of remission

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

604

C.14.03 Comorbid depression and anxiety disorders: New strategies for treating the full range of symptoms

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

605

C.14.04 The broad range of physical symptoms thatoccur with depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 245 KB

english, 2004

606

C.16.01 Generalized anxiety disorder: What are wemissing?

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

607

C.16.02 Generalized anxiety disorder: A comorbid disease

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 247 KB

english, 2004

608

C.16.03 Therapeutic options: Addressing the currentdilemma

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 237 KB

english, 2004

609

C.16.04 Pregabalin: From molecule to medicine

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 117 KB

english, 2004

610

C.18.01 Neurotransmitter imbalance in Alzheimer'sdisease — the role of glutamate

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 228 KB

english, 2004

611

C.18.02 Memantine — clinical data

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 116 KB

english, 2004

612

C.18.03 Alzheimer's disease and health economicanalyses

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 238 KB

english, 2004

613

C.18.04 Pros and cons of multiple therapy

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 151 KB

english, 2004

614

Author index

Journal:

European Neuropsychopharmacology

Year:

2004

File:

PDF, 1.10 MB

2004

615

Keyword index

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 496 KB

english, 2004

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски